No definition available.
Other congenital malformations of circulatory system
EFO MESH Endpoint Browser PheWeb
Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1015 |
4. Check minimum number of eventsNone |
1015 |
5. Include endpointsNone |
1015 |
6. Filter based on genotype QC (FinnGen only) |
984 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_CIRCULATO_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q2
- Name in latin
- Aliae malformationes congenitae systematis circulatorii
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of circulatory system
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of the circulatory system
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities, including avohilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5679 | 2954 | 2695 |
| Only index persons | 5251 | 2773 | 2478 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.08 | 0.08 |
| Only index persons | 0.10 | 0.10 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 50.81 | 51.53 | 50.08 |
| Only index persons | 51.08 | 51.74 | 50.35 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 984 | 575 | 409 |
| Unadjusted period prevalence (%) | 0.20 | 0.20 | 0.19 |
| Median age at first event (years) | 54.74 | 52.64 | 57.69 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1015
- Matched controls
- 10150
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
80.0
322.2
173
26
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
+∞
307.7
410
*
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
+∞
307.7
580
*
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
51.7
282.8
165
38
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
8.3
189.4
303
494
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
13.6
157.6
157
135
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
27.4
152.6
106
43
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
8.9
131.3
180
240
AA1AD
NOMESCO Finland
CT of head and brain
4.6
125.7
517
1882
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
18.4
121.7
100
60
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
40.4
111.1
68
18
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
23.4
103.7
76
35
N03AF02
ATC
oxcarbazepine; oral
9.4
98.4
125
150
AAC40
NOMESCO Finland
Extirpation of intracranial arterio-venous malformation
+∞
94.3
89
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.0
94.2
241
591
Q28.8
ICD-10 Finland
Other specified congenital malformations of circulatory system
+∞
84.6
80
*
PA2JT
NOMESCO Finland
Very extensive embolisation of arterio-venous malformation of the brain
+∞
77.1
73
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.8
73.5
286
946
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
11.5
73.1
78
73
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
10.5
72.2
82
84
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
15.1
71.3
64
45
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.0
71.1
78
76
N03AX14
ATC
levetiracetam; systemic
8.1
66.3
93
125
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
32.0
65.9
43
14
D18.0
ICD-10 Finland
Haemangioma, any site
9.6
65.7
80
90
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.4
64.2
98
145
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
9.2
63.5
80
94
XA800
NOMESCO Finland
Neuropsychological investigation
6.0
63.1
119
219
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
16.1
60.1
52
34
PA2AD
NOMESCO Finland
CT angiography of brain
18.8
56.2
45
25
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
19.9
53.9
42
22
PA2HT
NOMESCO Finland
Extensive embolisation of arterio-venous malformation of the brain
+∞
52.6
50
*
Q28.0
ICD-10 Finland
Arteriovenous malformation of precerebral vessels
+∞
52.6
50
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.1
49.5
111
238
H93.1
ICD-10 Finland
Tinnitus
4.1
49.0
149
407
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
131.3
47.2
50
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
13.6
44.5
42
32
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
44.4
357
1728
PA2GT
NOMESCO Finland
Embolisation of arterio-venous malformation of the brain
+∞
44.1
42
*
N03AF01
ATC
carbamazepine; oral, rectal
4.7
43.1
105
241
XCK00
NOMESCO Finland
Perimetry
4.4
39.5
106
262
Q28.1
ICD-10 Finland
Other malformations of precerebral vessels
+∞
38.8
37
*
G40.10
ICD-10 Finland
Simple partial seizures
14.5
38.4
35
25
R51.80
ICD-10 Finland
Headache
2.7
37.5
250
1091
N03AX18
ATC
lacosamide; systemic
13.4
36.7
35
27
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.5
35.4
52
73
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
10.9
35.0
38
36
ZXC95
NOMESCO Finland
Use of surgical navigator
9.5
34.1
41
45
ZXD35
NOMESCO Finland
Usual procedure
5.3
32.6
68
136
H53.4
ICD-10 Finland
Visual field defects
6.3
30.9
53
88
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
9.1
30.0
37
42
Q28.9
ICD-10 Finland
Congenital malformation of circulatory system, unspecified
+∞
29.3
28
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
28.9
417
2504
I77.0
ICD-10 Finland
Arteriovenous fistula, acquired
82.6
28.9
32
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
28.8
182
765
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
27.7
432
2660
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
27.2
211
976
R4110
NOMESCO Finland
Physiotherapy
2.1
26.2
338
1931
Z2445
NOMESCO Finland
Psychologist
3.9
25.5
77
207
H53.2
ICD-10 Finland
Diplopia
4.4
25.5
65
154
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
9.1
24.3
30
34
XX4AW, ,
NOMESCO Finland
57.5
24.1
28
5
R4150
NOMESCO Finland
Neuropsychological rehabilitation
9.0
23.4
29
33
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
85.4
22.8
25
*
R4120
NOMESCO Finland
Occupational therapy
3.1
22.4
102
357
183
Kela drug reimbursment
Lamotrigin and topiramate
8.5
22.3
29
35
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
64.0
21.9
25
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.6
21.5
72
208
Z3226
NOMESCO Finland
Physiotherapist
2.2
21.3
218
1125
Z3231
NOMESCO Finland
Registered nurse
2.0
21.3
310
1826
WX882
NOMESCO Finland
High dependency care
4.8
21.0
48
104
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.7
21.0
118
464
R20.2
ICD-10 Finland
Paraesthesia of skin
2.9
20.6
106
397
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
58.8
20.0
23
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
6.6
19.7
32
50
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
16.8
19.7
31
19
K91
ICPC
Cerebrovascular disease
7.0
19.6
30
44
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
8.2
18.8
25
31
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
28.4
18.8
25
9
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
7.8
18.8
26
34
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.0
18.7
89
319
N03AB02
ATC
phenytoin; systemic
7.0
18.3
28
41
G40
ICD-10 Finland
Epilepsy
7.3
18.3
27
38
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
15.7
18.0
29
19
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
29.4
17.5
23
8
K90
ICPC
Stroke/cerebrovascular accident
4.2
16.9
45
110
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
16.8
183
961
R51
ICD-10 Finland
Headache
2.9
16.5
82
301
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
16.3
167
857
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.7
15.8
25
38
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.6
15.7
53
154
AAC30
NOMESCO Finland
Intracranial occlusion of vascular fistula
+∞
15.7
15
*
Q27.3
ICD-10 Finland
Peripheral arteriovenous malformation
+∞
15.7
15
*
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
17.5
15.7
24
14
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.5
15.5
106
457
WX002
NOMESCO Finland
Sedation and analgesia
2.0
15.3
210
1195
AA5PD
NOMESCO Finland
CT examination of brain pefusion
12.0
15.1
27
23
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.2
15.0
60
194
N03AG01
ATC
valproic acid; systemic, rectal
2.6
14.5
86
346
G44.2
ICD-10 Finland
Tension-type headache
2.0
13.9
167
906
PA5AC
NOMESCO Finland
Angiography of arteries to the face with X-ray
141.8
13.5
14
*
R42
ICD-10 Finland
Dizziness and giddiness
1.8
13.4
240
1481
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
13.4
201
1174
H53.1
ICD-10 Finland
Subjective visual disturbances
2.5
13.4
89
379
AAF00
NOMESCO Finland
Ventriculostomy
14.0
13.3
22
16
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
4.3
13.2
34
81
M03BX01
ATC
baclofen; systemic
4.4
13.2
33
77
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.1
13.0
54
179
AA9CW, ,
NOMESCO Finland
28.8
13.0
17
6
N18
ICPC
Paralysis/weakness
4.5
12.9
31
70
Z2221
NOMESCO Finland
Medical doctor
1.7
12.7
284
1866
N03AX09
ATC
lamotrigine; oral
2.7
12.7
70
272
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.6
12.6
76
308
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
70.8
12.6
14
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
9.1
12.3
25
28
Z71.8
ICD-10 Finland
Other specified counselling
1.6
12.0
365
2593
ZXE00
NOMESCO Finland
One hour or less
1.6
11.9
389
2810
WX402
NOMESCO Finland
General anaesthesia
1.7
11.9
248
1594
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.9
11.7
34
89
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
11.6
90
410
PA5JT
NOMESCO Finland
Embolisation of very extensive arterio-venous malformation of carotis externa area
+∞
11.5
11
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
11.2
217
1363
WX892
NOMESCO Finland
Monitored bed care
2.3
11.1
87
398
TAB00
NOMESCO Finland
Lumbar puncture
2.7
11.0
62
243
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
15.7
10.8
17
11
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
10.8
80
357
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.1
10.7
29
72
XX4BW, ,
NOMESCO Finland
21.7
10.7
15
7
R55
ICD-10 Finland
Syncope and collapse
2.1
10.6
110
564
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
10.5
310
2171
7478X
ICD-9 Finland
Other congenital anomalies of circulatory system, Other specified anomalies of circulatory system
+∞
10.4
10
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
4.2
10.4
27
65
PA2CG
NOMESCO Finland
Extensive MRI examination of vessels in the head with high intensity magnet
16.2
10.4
16
10
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
3.4
10.3
37
112
ZXD05
NOMESCO Finland
Urgent procedure
1.6
10.3
301
2103
ZX050
NOMESCO Finland
Stereotactic radiotherapy
8.0
10.1
22
28
N88
ICPC
Epilepsy
8.6
10.1
21
25
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
10.0
464
3593
N02BE01
ATC
paracetamol; systemic, rectal
1.9
10.0
903
8182
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
14.8
10.0
16
11
PA6AD
NOMESCO Finland
CT of neck arteries
2.7
9.8
51
192
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
9.7
69
303
G40.89
ICD-10 Finland
Other epilepsy
13.5
9.7
16
12
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
9.2
9.5
19
21
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.0
9.5
106
558
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
17.7
9.4
14
8
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.0
9.3
99
512
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.8
9.2
44
159
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
9.1
9.0
18
20
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
15.7
9.0
14
9
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.1
8.8
37
124
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
10.8
8.8
16
15
N03AX16
ATC
[U] pregabalin
1.6
8.8
227
1530
PA7BD
NOMESCO Finland
CT angiography of neck and brain
4.3
8.7
22
52
N05BA01
ATC
diazepam; systemic, rectal
1.8
8.7
131
762
XKD00
NOMESCO Finland
Uroflowmetry
1.8
8.7
134
785
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.7
8.6
27
75
R60.0
ICD-10 Finland
Localized oedema
1.9
8.6
123
704
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
27.8
8.5
11
*
Q82.2
ICD-10 Finland
Mastocytosis
90.8
8.4
9
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
7.9
8.4
18
23
PG1JT
NOMESCO Finland
Very extensive endovascular embolisation of arterio-venous malformation not elsewhere classified
+∞
8.3
8
*
PG1GT
NOMESCO Finland
Endovascular embolisation of arterio-venous malformation with radiological guidance not elsewhere classified
+∞
8.3
8
*
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
8.3
64
291
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
2.7
8.3
43
162
T78.4
ICD-10 Finland
Allergy, unspecified
2.5
8.3
52
216
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
14.6
8.2
13
9
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.6
8.2
18
24
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
8.0
132
787
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.1
8.0
74
363
L28
ICPC
Limited function/disability (L)
1.7
8.0
169
1081
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
8.0
168
1074
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
7.9
66
311
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
7.9
118
684
J01MA02
ATC
ciprofloxacin; systemic
1.5
7.8
354
2693
R51.81
ICD-10 Finland
Facial pain NOS
3.1
7.8
32
106
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
15.2
7.7
12
8
G95.1
ICD-10 Finland
Vascular myelopathies
45.3
7.7
9
*
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
7.5
7.7
17
23
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.4
7.7
53
230
G81.9
ICD-10 Finland
Hemiplegia, unspecified
4.6
7.7
18
40
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
6.8
7.6
18
27
M79.6
ICD-10 Finland
Pain in limb
1.4
7.5
439
3500
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
4.3
7.5
19
45
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
7.4
718
6284
I62.9
ICD-10 Finland
Intracranial haemorrhage (nontraumatic), unspecified
80.7
7.4
8
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.8
7.4
119
705
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
4.1
7.4
20
50
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.7
7.4
140
870
R52.9
ICD-10 Finland
Pain, unspecified
1.8
7.3
109
630
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.7
7.3
23
64
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
7.3
389
3044
4301A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACH.POST MALFORMAT.ARTERIOVENOSAM]
+∞
7.3
7
*
AAA00
NOMESCO Finland
Exploratory craniotomy
+∞
7.3
7
*
Z2446
NOMESCO Finland
Social worker
2.0
7.2
74
378
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
30.2
7.2
9
*
I61.5
ICD-10 Finland
Intracerebral haemorrhage, intraventricular
30.2
7.2
9
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
7.1
59
277
I78.0
ICD-10 Finland
Hereditary haemorrhagic telangiectasia
20.2
7.1
10
5
G82.2
ICD-10 Finland
Paraplegia, unspecified
12.1
7.1
12
10
N03AX23
ATC
brivaracetam; systemic
12.1
7.1
12
10
H02.4
ICD-10 Finland
Ptosis of eyelid
2.8
7.1
35
129
WX872
NOMESCO Finland
Intensive care
2.3
7.0
52
233
RS222, ,
NOMESCO Finland
4.4
7.0
17
39
N19
ICPC
Speech disorder
4.0
6.9
19
48
M03BX02
ATC
tizanidine; oral
1.4
6.9
618
5294
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.1
6.8
61
297
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
16.8
6.8
10
6
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.2
6.7
26
83
N03AX12
ATC
[U] gabapentin; oral
1.6
6.7
158
1036
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
6.7
34
127
ZXA05
NOMESCO Finland
Left side
1.5
6.7
213
1498
I61.3
ICD-10 Finland
Intracerebral haemorrhage in brain stem
22.7
6.7
9
*
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
7.9
6.6
14
18
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.8
6.6
93
530
N99
ICPC
Neurological disease other
4.2
6.6
17
41
N06AX11
ATC
mirtazapine; oral
1.4
6.6
324
2489
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.9
6.6
19
50
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.4
6.5
42
177
WF099
NOMESCO Finland
Other radiotherapy
6.9
6.5
15
22
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
6.5
208
1464
ZXA00
NOMESCO Finland
Right side
1.5
6.5
236
1706
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.4
350
2734
G81.1
ICD-10 Finland
Spastic hemiplegia
70.3
6.4
7
*
PA5HT
NOMESCO Finland
Embolisation of extensive arterio-venous malformation of carotis externa area
70.3
6.4
7
*
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
70.3
6.4
7
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
6.4
131
829
UKC02
NOMESCO Finland
Cystoscopy
1.7
6.3
133
848
U07
ICPC
Urine symptom/complaint other
1.9
6.3
83
462
ZY010
NOMESCO Finland
Hospital outpatient
2.1
6.3
58
285
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
18.1
6.3
9
5
G992, Q288,
ICD-10 Finland
+∞
6.3
6
*
PG1HT
NOMESCO Finland
Extensive endovascular embolisation of arterio-venous malformation not elsewhere classified
+∞
6.3
6
*
PC6CC
NOMESCO Finland
Spinal angiography, very extensive
+∞
6.3
6
*
Q27.9
ICD-10 Finland
Congenital malformation of peripheral vascular system, unspecified
+∞
6.3
6
*
Q27.4
ICD-10 Finland
Congenital phlebectasia
+∞
6.3
6
*
Q28
ICD-10 Finland
Other congenital malformations of circulatory system
+∞
6.3
6
*
N03AF04
ATC
eslicarbazepine; oral
+∞
6.3
6
*
R41.3
ICD-10 Finland
Other amnesia
2.8
6.2
29
104
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
6.2
94
548
N28
ICPC
Limited function/disability (N)
3.4
6.2
21
62
XX3DW
NOMESCO Finland
Time consuming IT work
1.7
6.2
107
648
N03AE01
ATC
clonazepam; systemic
2.1
6.1
56
274
H05.2
ICD-10 Finland
Exophthalmic conditions
12.6
6.1
10
8
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.4
6.0
40
171
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
2.3
6.0
42
184
R4130
NOMESCO Finland
Speech therapy
2.7
6.0
32
123
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
6.0
139
908
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Neurosurgery
14 [38004459]
14 [38004459]
9.8e-01
2.6e+00
3.7e+00
—
5.0e+00
5.2e+00
3.2e+00
cases:6.44%
controls:2.51%
cases:11.20%
controls:0.93%
cases:5.55%
controls:0.14%
—
—
cases:16.10%
controls:0.13%
cases:58.27%
controls:0.74%
cases:38.09%
controls:2.37%
65
253
944
9828
113
94
896
9987
56
14
953
10067
—
161
13
839
10046
571
73
409
9750
331
206
538
8479
Neurology
13 [38004458]
13 [38004458]
7.1e-01
2.4e+00
3.1e+00
6.4e+00
3.2e+00
2.5e+00
1.8e+00
cases:17.54%
controls:9.46%
cases:33.50%
controls:4.32%
cases:15.86%
controls:0.80%
cases:23.19%
controls:0.05%
cases:18.40%
controls:0.87%
cases:35.92%
controls:4.20%
cases:40.28%
controls:10.03%
177
954
832
9127
338
436
671
9645
160
81
849
10000
234
5
775
10076
184
88
816
9971
352
413
628
9410
350
871
519
7814
oxcarbazepine; oral
N03AF02 [21604418]
N03AF02 [21604418]
1.6e+00
2.4e+00
2.9e+00
1.0e+50
3.4e+00
3.1e+00
2.8e+00
cases:2.38%
controls:0.49%
cases:4.16%
controls:0.39%
cases:2.68%
controls:0.15%
cases:0.50%
controls:0.00%
cases:3.10%
controls:0.11%
cases:7.04%
controls:0.35%
cases:7.48%
controls:0.47%
24
49
985
10032
42
39
967
10042
27
15
982
10066
5
0
1004
10081
31
11
969
10048
69
34
911
9789
65
41
804
8644
Inpatient Hospital
21 [8717]
21 [8717]
1.9e-01
1.0e+00
1.8e+00
6.0e+00
2.7e+00
1.6e+00
8.3e-01
cases:34.09%
controls:29.90%
cases:21.90%
controls:9.00%
cases:7.33%
controls:1.23%
cases:25.97%
controls:0.09%
cases:14.70%
controls:1.16%
cases:30.31%
controls:8.06%
cases:37.97%
controls:21.06%
344
3014
665
7067
221
907
788
9174
74
124
935
9957
262
9
747
10072
147
117
853
9942
297
792
683
9031
330
1829
539
6856
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
G40.22 [2000502141]
1.4e+00
1.9e+00
2.8e+00
1.0e+50
3.0e+00
2.6e+00
2.4e+00
cases:1.09%
controls:0.28%
cases:1.59%
controls:0.25%
cases:0.79%
controls:0.05%
cases:0.59%
controls:0.00%
cases:1.00%
controls:0.05%
cases:3.06%
controls:0.24%
cases:4.49%
controls:0.44%
11
28
998
10053
16
25
993
10056
8
5
1001
10076
6
0
1003
10081
10
5
990
10054
30
24
950
9799
39
38
830
8647
Outpatient Hospital
22 [8756]
22 [8756]
1.7e-01
9.0e-01
1.7e+00
5.7e+00
2.4e+00
1.8e+00
1.0e+00
cases:26.66%
controls:23.48%
cases:14.77%
controls:6.60%
cases:4.36%
controls:0.82%
cases:17.34%
controls:0.07%
cases:8.60%
controls:0.86%
cases:27.86%
controls:5.88%
cases:34.29%
controls:15.65%
269
2367
740
7714
149
665
860
9416
44
83
965
9998
175
7
834
10074
86
87
914
9972
273
578
707
9245
298
1359
571
7326
carbamazepine; oral, rectal
N03AF01 [21604417]
N03AF01 [21604417]
1.5e+00
2.1e+00
2.6e+00
—
2.3e+00
2.3e+00
2.1e+00
cases:3.27%
controls:0.75%
cases:3.67%
controls:0.45%
cases:1.09%
controls:0.08%
—
—
cases:1.50%
controls:0.16%
cases:4.49%
controls:0.47%
cases:5.29%
controls:0.66%
33
76
976
10005
37
45
972
10036
11
8
998
10073
—
15
16
985
10043
44
46
936
9777
46
57
823
8628
levetiracetam; oral, parenteral
N03AX14 [21604436]
N03AX14 [21604436]
1.2e+00
1.7e+00
2.2e+00
—
3.2e+00
2.6e+00
2.4e+00
cases:1.19%
controls:0.38%
cases:1.98%
controls:0.37%
cases:1.39%
controls:0.16%
—
—
cases:2.10%
controls:0.09%
cases:4.80%
controls:0.37%
cases:4.83%
controls:0.44%
12
38
997
10043
20
37
989
10044
14
16
995
10065
—
21
9
979
10050
47
36
933
9787
42
38
827
8647
Headache
R51.80 [2000503603]
R51.80 [2000503603]
5.3e-01
2.0e+00
3.5e+00
1.0e+50
2.8e+00
2.3e+00
1.4e+00
cases:3.47%
controls:2.07%
cases:4.16%
controls:0.61%
cases:2.28%
controls:0.07%
cases:2.18%
controls:0.00%
cases:1.50%
controls:0.09%
cases:4.90%
controls:0.53%
cases:7.83%
controls:2.15%
35
209
974
9872
42
61
967
10020
23
7
986
10074
22
0
987
10081
15
9
985
10050
48
52
932
9771
68
187
801
8498
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
AA1DG [2001300120]
1.8e+00
3.2e+00
1.0e+50
—
1.0e+50
3.6e+00
2.9e+00
cases:1.19%
controls:0.21%
cases:2.18%
controls:0.09%
cases:1.19%
controls:0.00%
—
—
cases:0.90%
controls:0.00%
cases:2.45%
controls:0.07%
cases:4.14%
controls:0.23%
12
21
997
10060
22
9
987
10072
12
0
997
10081
—
9
0
991
10059
24
7
956
9816
36
20
833
8665
Emergency Room Visit
ER [9203]
ER [9203]
2.7e-01
1.1e+00
2.2e+00
4.7e+00
1.6e+00
8.3e-01
6.8e-01
cases:38.45%
controls:32.35%
cases:26.76%
controls:10.77%
cases:10.70%
controls:1.33%
cases:10.90%
controls:0.11%
cases:6.00%
controls:1.24%
cases:20.31%
controls:10.02%
cases:43.04%
controls:27.60%
388
3261
621
6820
270
1086
739
8995
108
134
901
9947
110
11
899
10070
60
125
940
9934
199
984
781
8839
374
2397
495
6288
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
4.7e-01
1.3e+00
3.4e+00
—
3.1e+00
2.0e+00
8.9e-01
cases:6.84%
controls:4.38%
cases:8.03%
controls:2.27%
cases:6.24%
controls:0.23%
—
—
cases:5.00%
controls:0.24%
cases:14.90%
controls:2.25%
cases:13.00%
controls:5.78%
69
442
940
9639
81
229
928
9852
63
23
946
10058
—
50
24
950
10035
146
221
834
9602
113
502
756
8183
Cerebral aneurysm, nonruptured
I67.1 [45538401]
I67.1 [45538401]
1.5e+00
2.4e+00
—
1.0e+50
—
4.4e+00
2.8e+00
cases:0.89%
controls:0.20%
cases:1.09%
controls:0.10%
—
—
cases:1.68%
controls:0.00%
—
—
cases:4.69%
controls:0.06%
cases:3.91%
controls:0.25%
9
20
1000
10061
11
10
998
10071
—
17
0
992
10081
—
46
6
934
9817
34
22
835
8663
Epilepsy
G40 [45595935]
G40 [45595935]
1.9e+00
2.8e+00
—
—
—
3.3e+00
2.8e+00
cases:1.39%
controls:0.21%
cases:1.49%
controls:0.09%
—
—
—
—
—
—
cases:2.24%
controls:0.08%
cases:3.45%
controls:0.22%
14
21
995
10060
15
9
994
10072
—
—
—
22
8
958
9815
30
19
839
8666
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 [2000502142]
G40.29 [2000502142]
2.3e+00
2.8e+00
—
1.0e+50
—
3.1e+00
2.6e+00
cases:0.99%
controls:0.10%
cases:1.29%
controls:0.08%
—
—
cases:0.50%
controls:0.00%
—
—
cases:2.24%
controls:0.10%
cases:3.91%
controls:0.30%
10
10
999
10071
13
8
996
10073
—
5
0
1004
10081
—
22
10
958
9813
34
26
835
8659
Outpatient Visit
OP [9202]
OP [9202]
2.0e-01
9.0e-01
9.2e-01
5.0e+00
1.1e+00
1.5e+00
1.3e+00
cases:73.24%
controls:69.16%
cases:68.68%
controls:47.15%
cases:23.59%
controls:10.92%
cases:39.74%
controls:0.46%
cases:26.60%
controls:10.37%
cases:80.41%
controls:48.56%
cases:92.17%
controls:76.95%
739
6972
270
3109
693
4753
316
5328
238
1101
771
8980
401
46
608
10035
266
1043
734
9016
788
4770
192
5053
801
6683
68
2002
Cerebral infarction, unspecified
I63.9 [45596216]
I63.9 [45596216]
-6.6e-02
1.9e+00
2.9e+00
1.0e+50
2.9e+00
1.9e+00
9.3e-01
cases:0.89%
controls:0.95%
cases:2.08%
controls:0.32%
cases:1.09%
controls:0.06%
cases:0.99%
controls:0.00%
cases:0.90%
controls:0.05%
cases:2.04%
controls:0.33%
cases:2.88%
controls:1.15%
9
96
1000
9985
21
32
988
10049
11
6
998
10075
10
0
999
10081
9
5
991
10054
20
32
960
9791
25
100
844
8585
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
7.9e-01
1.3e+00
2.0e+00
—
2.9e+00
1.8e+00
1.5e+00
cases:5.25%
controls:2.45%
cases:2.08%
controls:0.60%
cases:0.89%
controls:0.12%
—
—
cases:1.80%
controls:0.10%
cases:3.57%
controls:0.63%
cases:5.52%
controls:1.23%
53
247
956
9834
21
60
988
10021
9
12
1000
10069
—
18
10
982
10049
35
62
945
9761
48
107
821
8578
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
-3.3e-02
8.6e-01
1.6e+00
4.3e+00
1.2e+00
1.3e+00
7.0e-01
cases:7.93%
controls:8.17%
cases:10.31%
controls:4.65%
cases:6.54%
controls:1.46%
cases:3.57%
controls:0.05%
cases:4.70%
controls:1.49%
cases:15.41%
controls:4.75%
cases:19.68%
controls:10.85%
80
824
929
9257
104
469
905
9612
66
147
943
9934
36
5
973
10076
47
150
953
9909
151
467
829
9356
171
942
698
7743
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
4.7e-01
1.9e+00
3.4e+00
1.0e+50
2.2e+00
1.3e+00
8.0e-01
cases:3.37%
controls:2.14%
cases:5.95%
controls:0.94%
cases:2.08%
controls:0.07%
cases:2.08%
controls:0.00%
cases:1.30%
controls:0.14%
cases:2.96%
controls:0.83%
cases:6.33%
controls:2.95%
34
216
975
9865
60
95
949
9986
21
7
988
10074
21
0
988
10081
13
14
987
10045
29
82
951
9741
55
256
814
8429
Emergency Medicine
93 [38004510]
93 [38004510]
1.2e-01
8.5e-01
1.8e+00
4.5e+00
1.1e+00
6.2e-01
3.1e-01
cases:13.88%
controls:12.48%
cases:13.88%
controls:6.45%
cases:4.86%
controls:0.83%
cases:5.65%
controls:0.07%
cases:2.70%
controls:0.95%
cases:11.94%
controls:6.82%
cases:26.24%
controls:20.66%
140
1258
869
8823
140
650
869
9431
49
84
960
9997
57
7
952
10074
27
96
973
9963
117
670
863
9153
228
1794
641
6891
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
3.7e-01
1.3e+00
—
—
3.9e+00
2.5e+00
1.4e+00
cases:5.45%
controls:3.82%
cases:3.07%
controls:0.89%
—
—
—
—
cases:2.30%
controls:0.05%
cases:7.45%
controls:0.68%
cases:7.83%
controls:2.00%
55
385
954
9696
31
90
978
9991
—
—
23
5
977
10054
73
67
907
9756
68
174
801
8511
Other and unspecified convulsions
R56.8 [45602033]
R56.8 [45602033]
1.1e+00
3.3e+00
—
1.0e+50
—
2.7e+00
1.8e+00
cases:1.29%
controls:0.43%
cases:3.27%
controls:0.13%
—
—
cases:1.09%
controls:0.00%
—
—
cases:2.45%
controls:0.17%
cases:2.53%
controls:0.41%
13
43
996
10038
33
13
976
10068
—
11
0
998
10081
—
24
17
956
9806
22
36
847
8649
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
6.1e-01
1.1e+00
—
1.0e+50
4.0e+00
3.1e+00
1.5e+00
cases:0.89%
controls:0.49%
cases:0.79%
controls:0.27%
—
—
cases:0.99%
controls:0.00%
cases:3.30%
controls:0.06%
cases:6.84%
controls:0.32%
cases:4.03%
controls:0.92%
9
49
1000
10032
8
27
1001
10054
—
10
0
999
10081
33
6
967
10053
67
31
913
9792
35
80
834
8605
Occupational therapy
R4120 [2001310234]
R4120 [2001310234]
8.0e-01
1.8e+00
—
1.0e+50
3.2e+00
2.3e+00
1.4e+00
cases:1.19%
controls:0.54%
cases:1.09%
controls:0.19%
—
—
cases:0.59%
controls:0.00%
cases:1.20%
controls:0.05%
cases:2.14%
controls:0.22%
cases:2.99%
controls:0.74%
12
54
997
10027
11
19
998
10062
—
6
0
1003
10081
12
5
988
10054
21
22
959
9801
26
64
843
8621
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
AA1CG [2001300116]
6.7e-01
2.9e+00
—
1.0e+50
—
3.0e+00
2.5e+00
cases:1.88%
controls:0.97%
cases:6.84%
controls:0.42%
—
—
cases:4.86%
controls:0.00%
—
—
cases:6.53%
controls:0.35%
cases:8.98%
controls:0.79%
19
98
990
9983
69
42
940
10039
—
49
0
960
10081
—
64
34
916
9789
78
69
791
8616
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
4.8e-01
1.0e+00
1.7e+00
—
2.4e+00
1.6e+00
1.1e+00
cases:7.23%
controls:4.62%
cases:4.46%
controls:1.63%
cases:1.68%
controls:0.33%
—
—
cases:3.30%
controls:0.30%
cases:7.35%
controls:1.60%
cases:11.16%
controls:3.83%
73
466
936
9615
45
164
964
9917
17
33
992
10048
—
33
30
967
10029
72
157
908
9666
97
333
772
8352
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
2.3e-01
1.5e+00
2.7e+00
—
2.3e+00
1.1e+00
5.9e-01
cases:6.24%
controls:5.05%
cases:8.03%
controls:1.85%
cases:3.37%
controls:0.23%
—
—
cases:2.60%
controls:0.27%
cases:5.92%
controls:1.95%
cases:11.97%
controls:7.00%
63
509
946
9572
81
187
928
9894
34
23
975
10058
—
26
27
974
10032
58
192
922
9631
104
608
765
8077
Tinnitus
H93.1 [45543152]
H93.1 [45543152]
1.0e+00
3.6e+00
—
1.0e+50
—
2.6e+00
1.0e+00
cases:1.98%
controls:0.71%
cases:7.93%
controls:0.24%
—
—
cases:0.59%
controls:0.00%
—
—
cases:2.65%
controls:0.20%
cases:2.53%
controls:0.94%
20
72
989
10009
80
24
929
10057
—
6
0
1003
10081
—
26
20
954
9803
22
82
847
8603
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
3.0e-02
6.5e-01
1.7e+00
—
3.1e+00
1.9e+00
8.2e-01
cases:5.55%
controls:5.40%
cases:4.46%
controls:2.37%
cases:1.29%
controls:0.25%
—
—
cases:4.20%
controls:0.19%
cases:12.96%
controls:2.09%
cases:13.23%
controls:6.32%
56
544
953
9537
45
239
964
9842
13
25
996
10056
—
42
19
958
10040
127
205
853
9618
115
549
754
8136
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
2.3e-01
8.4e-01
2.2e+00
—
2.6e+00
1.7e+00
6.4e-01
cases:2.18%
controls:1.75%
cases:2.08%
controls:0.91%
cases:0.59%
controls:0.07%
—
—
cases:1.20%
controls:0.09%
cases:5.61%
controls:1.04%
cases:6.44%
controls:3.49%
22
176
987
9905
21
92
988
9989
6
7
1003
10074
—
12
9
988
10050
55
102
925
9721
56
303
813
8382
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
-1.3e-01
8.4e-01
—
1.0e+50
4.1e+00
2.7e+00
1.1e+00
cases:1.29%
controls:1.47%
cases:1.19%
controls:0.52%
—
—
cases:1.09%
controls:0.00%
cases:4.00%
controls:0.07%
cases:9.08%
controls:0.67%
cases:5.87%
controls:2.06%
13
148
996
9933
12
52
997
10029
—
11
0
998
10081
40
7
960
10052
89
66
891
9757
51
179
818
8506
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
-1.3e-01
8.6e-01
—
1.0e+50
4.1e+00
2.7e+00
1.0e+00
cases:1.29%
controls:1.47%
cases:1.19%
controls:0.51%
—
—
cases:1.09%
controls:0.00%
cases:4.00%
controls:0.07%
cases:9.08%
controls:0.66%
cases:5.75%
controls:2.12%
13
148
996
9933
12
51
997
10030
—
11
0
998
10081
40
7
960
10052
89
65
891
9758
50
184
819
8501
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
-1.3e-01
8.6e-01
—
1.0e+50
4.1e+00
2.7e+00
1.0e+00
cases:1.29%
controls:1.47%
cases:1.19%
controls:0.51%
—
—
cases:1.09%
controls:0.00%
cases:4.00%
controls:0.07%
cases:9.08%
controls:0.66%
cases:5.75%
controls:2.12%
13
148
996
9933
12
51
997
10030
—
11
0
998
10081
40
7
960
10052
89
65
891
9758
50
184
819
8501
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
AA1BG [2001300112]
8.0e-01
2.7e+00
—
1.0e+50
—
2.4e+00
1.9e+00
cases:2.48%
controls:1.13%
cases:4.56%
controls:0.32%
—
—
cases:2.48%
controls:0.00%
—
—
cases:4.18%
controls:0.40%
cases:7.25%
controls:1.12%
25
114
984
9967
46
32
963
10049
—
25
0
984
10081
—
41
39
939
9784
63
97
806
8588
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
-1.5e-01
8.4e-01
—
1.0e+50
3.9e+00
2.7e+00
1.1e+00
cases:1.29%
controls:1.49%
cases:1.19%
controls:0.52%
—
—
cases:1.09%
controls:0.00%
cases:3.90%
controls:0.08%
cases:9.08%
controls:0.66%
cases:5.98%
controls:2.06%
13
150
996
9931
12
52
997
10029
—
11
0
998
10081
39
8
961
10051
89
65
891
9758
52
179
817
8506
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
5.3e-01
9.6e-01
—
—
2.7e+00
2.1e+00
1.4e+00
cases:9.61%
controls:5.89%
cases:3.77%
controls:1.48%
—
—
—
—
cases:3.20%
controls:0.23%
cases:10.31%
controls:1.36%
cases:12.08%
controls:3.29%
97
594
912
9487
38
149
971
9932
—
—
32
23
968
10036
101
134
879
9689
105
286
764
8399
Psychologist
Z2445 [2001311558]
Z2445 [2001311558]
8.3e-01
1.7e+00
—
—
—
2.9e+00
3.0e+00
cases:0.99%
controls:0.44%
cases:0.89%
controls:0.16%
—
—
—
—
—
—
cases:2.14%
controls:0.12%
cases:2.99%
controls:0.15%
10
44
999
10037
9
16
1000
10065
—
—
—
21
12
959
9811
26
13
843
8672
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
4.3e-02
4.1e-01
1.2e+00
3.9e+00
1.4e+00
6.0e-01
2.1e-01
cases:30.43%
controls:29.53%
cases:27.95%
controls:20.42%
cases:11.99%
controls:3.76%
cases:6.44%
controls:0.14%
cases:12.50%
controls:3.33%
cases:32.45%
controls:20.93%
cases:47.53%
controls:42.33%
307
2977
702
7104
282
2059
727
8022
121
379
888
9702
65
14
944
10067
125
335
875
9724
318
2056
662
7767
413
3676
456
5009
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
1.3e-01
1.3e+00
2.2e+00
1.0e+50
—
2.8e+00
1.2e+00
cases:2.38%
controls:2.10%
cases:1.88%
controls:0.51%
cases:0.59%
controls:0.07%
cases:4.76%
controls:0.00%
—
—
cases:9.39%
controls:0.61%
cases:6.56%
controls:2.00%
24
212
985
9869
19
51
990
10030
6
7
1003
10074
48
0
961
10081
—
92
60
888
9763
57
174
812
8511
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
4.0e-02
5.2e-01
1.2e+00
3.7e+00
1.5e+00
6.5e-01
2.2e-01
cases:27.85%
controls:27.06%
cases:26.46%
controls:17.62%
cases:10.41%
controls:3.31%
cases:7.53%
controls:0.21%
cases:12.60%
controls:3.24%
cases:30.41%
controls:18.51%
cases:45.11%
controls:39.70%
281
2728
728
7353
267
1776
742
8305
105
334
904
9747
76
21
933
10060
126
326
874
9733
298
1818
682
8005
392
3448
477
5237
Diplopia
H53.2 [45576792]
H53.2 [45576792]
9.6e-01
2.7e+00
—
1.0e+50
1.0e+50
3.2e+00
1.6e+00
cases:0.59%
controls:0.23%
cases:1.88%
controls:0.13%
—
—
cases:0.59%
controls:0.00%
cases:0.50%
controls:0.00%
cases:1.53%
controls:0.06%
cases:1.38%
controls:0.29%
6
23
1003
10058
19
13
990
10068
—
6
0
1003
10081
5
0
995
10059
15
6
965
9817
12
25
857
8660
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
4.8e-01
9.6e-01
1.3e+00
—
2.9e+00
1.9e+00
1.2e+00
cases:8.42%
controls:5.37%
cases:4.06%
controls:1.60%
cases:0.50%
controls:0.14%
—
—
cases:2.50%
controls:0.14%
cases:7.65%
controls:1.19%
cases:10.24%
controls:3.24%
85
541
924
9540
41
161
968
9920
5
14
1004
10067
—
25
14
975
10045
75
117
905
9706
89
281
780
8404
Epilepsy, unspecified
G40.9 [45562083]
G40.9 [45562083]
8.1e-01
2.1e+00
—
1.0e+50
—
2.9e+00
2.5e+00
cases:0.89%
controls:0.40%
cases:1.49%
controls:0.19%
—
—
cases:0.50%
controls:0.00%
—
—
cases:2.55%
controls:0.14%
cases:4.14%
controls:0.36%
9
40
1000
10041
15
19
994
10062
—
5
0
1004
10081
—
25
14
955
9809
36
31
833
8654
Neuropsychological investigation
XA800 [2001300412]
XA800 [2001300412]
8.4e-01
1.9e+00
—
1.0e+50
—
2.9e+00
2.6e+00
cases:0.89%
controls:0.39%
cases:1.39%
controls:0.21%
—
—
cases:0.50%
controls:0.00%
—
—
cases:3.47%
controls:0.19%
cases:4.72%
controls:0.38%
9
39
1000
10042
14
21
995
10060
—
5
0
1004
10081
—
34
19
946
9804
41
33
828
8652
Epilepsy and comparable convulsive disorders
111 [2001600111]
111 [2001600111]
1.6e+00
2.8e+00
—
—
1.0e+50
—
2.8e+00
cases:1.09%
controls:0.22%
cases:1.98%
controls:0.12%
—
—
—
—
cases:1.40%
controls:0.00%
—
—
cases:3.34%
controls:0.21%
11
22
998
10059
20
12
989
10069
—
—
14
0
986
10059
—
29
18
840
8667
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
6.0e-01
1.0e+00
—
—
3.4e+00
2.7e+00
1.2e+00
cases:1.49%
controls:0.82%
cases:1.29%
controls:0.46%
—
—
—
—
cases:2.80%
controls:0.10%
cases:5.71%
controls:0.41%
cases:3.45%
controls:1.12%
15
83
994
9998
13
46
996
10035
—
—
28
10
972
10049
56
40
924
9783
30
97
839
8588
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.2e-03
3.4e-01
1.2e+00
3.4e+00
1.3e+00
6.3e-01
2.4e-01
cases:28.84%
controls:28.82%
cases:28.84%
controls:22.41%
cases:12.78%
controls:4.11%
cases:8.03%
controls:0.29%
cases:14.50%
controls:4.22%
cases:36.94%
controls:23.83%
cases:50.63%
controls:44.58%
291
2905
718
7176
291
2259
718
7822
129
414
880
9667
81
29
928
10052
145
424
855
9635
362
2341
618
7482
440
3872
429
4813
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
5.2e-02
3.8e-01
1.4e+00
3.1e+00
1.3e+00
6.5e-01
2.9e-01
cases:21.90%
controls:21.02%
cases:24.38%
controls:18.07%
cases:13.28%
controls:3.69%
cases:5.65%
controls:0.26%
cases:12.00%
controls:3.69%
cases:31.02%
controls:18.96%
cases:43.04%
controls:36.06%
221
2119
788
7962
246
1822
763
8259
134
372
875
9709
57
26
952
10055
120
371
880
9688
304
1862
676
7961
374
3132
495
5553
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
R29.8 [45587505]
1.1e+00
2.2e+00
—
1.0e+50
—
2.5e+00
1.4e+00
cases:2.18%
controls:0.77%
cases:2.28%
controls:0.27%
—
—
cases:0.50%
controls:0.00%
—
—
cases:2.65%
controls:0.21%
cases:3.22%
controls:0.85%
22
78
987
10003
23
27
986
10054
—
5
0
1004
10081
—
26
21
954
9802
28
74
841
8611
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
2.1e-03
3.4e-01
1.1e+00
3.4e+00
1.3e+00
5.9e-01
2.4e-01
cases:29.04%
controls:29.00%
cases:29.14%
controls:22.71%
cases:12.09%
controls:4.18%
cases:7.83%
controls:0.29%
cases:14.40%
controls:4.24%
cases:36.43%
controls:24.15%
cases:50.86%
controls:44.91%
293
2923
716
7158
294
2289
715
7792
122
421
887
9660
79
29
930
10052
144
426
856
9633
357
2372
623
7451
442
3900
427
4785
Sequelae of intracerebral haemorrhage
I69.1 [45538404]
I69.1 [45538404]
—
—
—
—
—
3.8e+00
3.2e+00
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:0.06%
cases:3.34%
controls:0.14%
—
—
—
—
—
26
6
954
9817
29
12
840
8673
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
1.4e-01
6.3e-01
2.4e+00
1.0e+50
2.5e+00
1.3e+00
6.9e-01
cases:4.26%
controls:3.73%
cases:1.78%
controls:0.96%
cases:0.79%
controls:0.07%
cases:2.78%
controls:0.00%
cases:1.30%
controls:0.11%
cases:3.16%
controls:0.89%
cases:5.75%
controls:2.97%
43
376
966
9705
18
97
991
9984
8
7
1001
10074
28
0
981
10081
13
11
987
10048
31
87
949
9736
50
258
819
8427
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
-9.1e-03
3.6e-01
1.4e+00
3.3e+00
1.3e+00
6.0e-01
2.1e-01
cases:31.42%
controls:31.61%
cases:33.99%
controls:26.47%
cases:18.24%
controls:5.41%
cases:8.13%
controls:0.32%
cases:16.70%
controls:5.32%
cases:41.53%
controls:28.10%
cases:54.55%
controls:49.42%
317
3187
692
6894
343
2668
666
7413
184
545
825
9536
82
32
927
10049
167
535
833
9524
407
2760
573
7063
474
4292
395
4393
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
-7.7e-02
8.0e-01
2.3e+00
—
2.1e+00
1.3e+00
4.2e-01
cases:10.01%
controls:10.72%
cases:11.30%
controls:5.41%
cases:4.96%
controls:0.52%
—
—
cases:6.40%
controls:0.85%
cases:17.45%
controls:5.70%
cases:22.09%
controls:15.71%
101
1081
908
9000
114
545
895
9536
50
52
959
10029
—
64
85
936
9974
171
560
809
9263
192
1364
677
7321
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
1.2e-02
8.0e-01
1.5e+00
—
2.4e+00
1.4e+00
7.2e-01
cases:8.42%
controls:8.33%
cases:5.25%
controls:2.42%
cases:1.39%
controls:0.31%
—
—
cases:3.30%
controls:0.32%
cases:7.24%
controls:1.86%
cases:10.59%
controls:5.43%
85
840
924
9241
53
244
956
9837
14
31
995
10050
—
33
32
967
10027
71
183
909
9640
92
472
777
8213
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
-5.7e-02
3.3e-01
1.3e+00
3.4e+00
1.2e+00
5.9e-01
2.4e-01
cases:21.21%
controls:22.18%
cases:23.69%
controls:18.29%
cases:12.59%
controls:3.88%
cases:6.24%
controls:0.22%
cases:11.80%
controls:3.91%
cases:29.39%
controls:18.80%
cases:40.97%
controls:35.33%
214
2236
795
7845
239
1844
770
8237
127
391
882
9690
63
22
946
10059
118
393
882
9666
288
1847
692
7976
356
3068
513
5617
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
-1.1e-01
4.8e-01
2.2e+00
1.0e+50
3.0e+00
1.6e+00
1.7e-02
cases:4.16%
controls:4.61%
cases:2.68%
controls:1.68%
cases:1.19%
controls:0.14%
cases:1.88%
controls:0.00%
cases:2.30%
controls:0.12%
cases:6.84%
controls:1.50%
cases:5.64%
controls:5.55%
42
465
967
9616
27
169
982
9912
12
14
997
10067
19
0
990
10081
23
12
977
10047
67
147
913
9676
49
482
820
8203
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
4.6e-01
—
—
1.0e+50
3.5e+00
2.3e+00
8.0e-01
cases:1.09%
controls:0.69%
—
—
—
—
cases:0.79%
controls:0.00%
cases:1.70%
controls:0.05%
cases:4.29%
controls:0.45%
cases:2.65%
controls:1.21%
11
70
998
10011
—
—
8
0
1001
10081
17
5
983
10054
42
44
938
9779
23
105
846
8580
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
-3.3e-02
3.4e-01
1.2e+00
3.4e+00
1.2e+00
5.1e-01
1.9e-01
cases:34.29%
controls:35.04%
cases:37.46%
controls:29.87%
cases:18.14%
controls:6.53%
cases:8.92%
controls:0.34%
cases:18.20%
controls:6.03%
cases:43.06%
controls:31.15%
cases:58.46%
controls:53.77%
346
3532
663
6549
378
3011
631
7070
183
658
826
9423
90
34
919
10047
182
607
818
9452
422
3060
558
6763
508
4670
361
4015
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
-3.6e-02
3.4e-01
1.2e+00
3.4e+00
1.2e+00
5.1e-01
1.9e-01
cases:34.29%
controls:35.11%
cases:37.56%
controls:29.96%
cases:18.14%
controls:6.53%
cases:8.92%
controls:0.34%
cases:18.20%
controls:6.04%
cases:43.06%
controls:31.17%
cases:58.46%
controls:53.83%
346
3539
663
6542
379
3020
630
7061
183
658
826
9423
90
34
919
10047
182
608
818
9451
422
3062
558
6761
508
4675
361
4010
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
-3.8e-02
3.4e-01
1.2e+00
3.4e+00
1.2e+00
5.1e-01
1.9e-01
cases:34.29%
controls:35.16%
cases:37.56%
controls:30.01%
cases:18.14%
controls:6.52%
cases:8.92%
controls:0.34%
cases:18.20%
controls:6.04%
cases:43.06%
controls:31.20%
cases:58.46%
controls:53.87%
346
3544
663
6537
379
3025
630
7056
183
657
826
9424
90
34
919
10047
182
608
818
9451
422
3065
558
6758
508
4679
361
4006
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
-3.8e-02
3.4e-01
1.2e+00
3.4e+00
1.2e+00
5.1e-01
1.8e-01
cases:34.29%
controls:35.16%
cases:37.56%
controls:30.02%
cases:18.14%
controls:6.54%
cases:8.92%
controls:0.34%
cases:18.20%
controls:6.04%
cases:43.06%
controls:31.23%
cases:58.46%
controls:53.91%
346
3544
663
6537
379
3026
630
7055
183
659
826
9422
90
34
919
10047
182
608
818
9451
422
3068
558
6755
508
4682
361
4003
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
-4.2e-02
3.5e-01
1.1e+00
3.4e+00
1.2e+00
5.1e-01
1.8e-01
cases:34.29%
controls:35.24%
cases:37.76%
controls:30.05%
cases:18.14%
controls:6.56%
cases:8.92%
controls:0.34%
cases:18.20%
controls:6.05%
cases:43.06%
controls:31.28%
cases:58.34%
controls:53.96%
346
3553
663
6528
381
3029
628
7052
183
661
826
9420
90
34
919
10047
182
609
818
9450
422
3073
558
6750
507
4686
362
3999
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
-4.2e-02
3.4e-01
1.2e+00
3.3e+00
1.2e+00
5.1e-01
1.8e-01
cases:34.19%
controls:35.15%
cases:37.56%
controls:30.06%
cases:18.14%
controls:6.55%
cases:8.92%
controls:0.35%
cases:18.20%
controls:6.05%
cases:43.16%
controls:31.30%
cases:58.46%
controls:53.91%
345
3543
664
6538
379
3030
630
7051
183
660
826
9421
90
35
919
10046
182
609
818
9450
423
3075
557
6748
508
4682
361
4003
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
-3.9e-02
3.4e-01
1.1e+00
3.3e+00
1.2e+00
5.1e-01
1.9e-01
cases:34.29%
controls:35.18%
cases:37.56%
controls:30.04%
cases:18.14%
controls:6.56%
cases:8.92%
controls:0.35%
cases:18.20%
controls:6.05%
cases:43.06%
controls:31.22%
cases:58.46%
controls:53.89%
346
3546
663
6535
379
3028
630
7053
183
661
826
9420
90
35
919
10046
182
609
818
9450
422
3067
558
6756
508
4680
361
4005
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
1.9e-01
1.1e+00
2.8e+00
—
—
1.8e+00
8.2e-01
cases:1.98%
controls:1.65%
cases:1.88%
controls:0.62%
cases:1.09%
controls:0.07%
—
—
—
—
cases:2.76%
controls:0.47%
cases:3.91%
controls:1.76%
20
166
989
9915
19
62
990
10019
11
7
998
10074
—
—
27
46
953
9777
34
153
835
8532
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
-8.0e-02
3.7e-01
7.1e-01
4.4e+00
1.3e+00
3.9e-01
1.9e-01
cases:13.28%
controls:14.23%
cases:10.31%
controls:7.33%
cases:2.48%
controls:1.23%
cases:4.66%
controls:0.06%
cases:4.20%
controls:1.17%
cases:11.12%
controls:7.82%
cases:23.59%
controls:20.29%
134
1435
875
8646
104
739
905
9342
25
124
984
9957
47
6
962
10075
42
118
958
9941
109
768
871
9055
205
1762
664
6923
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
-7.4e-02
2.9e-01
—
1.0e+50
3.5e+00
2.2e+00
7.5e-01
cases:1.19%
controls:1.28%
cases:0.59%
controls:0.45%
—
—
cases:0.79%
controls:0.00%
cases:2.20%
controls:0.07%
cases:5.10%
controls:0.60%
cases:4.03%
controls:1.95%
12
129
997
9952
6
45
1003
10036
—
8
0
1001
10081
22
7
978
10052
50
59
930
9764
35
169
834
8516
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
-1.4e-02
2.8e-01
1.2e+00
3.3e+00
1.2e+00
5.0e-01
1.5e-01
cases:25.77%
controls:26.03%
cases:25.57%
controls:20.65%
cases:12.69%
controls:4.35%
cases:5.75%
controls:0.23%
cases:12.00%
controls:4.09%
cases:31.33%
controls:21.59%
cases:44.30%
controls:40.61%
260
2624
749
7457
258
2082
751
7999
128
439
881
9642
58
23
951
10058
120
411
880
9648
307
2121
673
7702
385
3527
484
5158
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
-7.6e-02
3.8e-01
1.4e+00
—
2.7e+00
1.7e+00
5.0e-01
cases:7.43%
controls:7.98%
cases:5.15%
controls:3.58%
cases:1.59%
controls:0.39%
—
—
cases:5.00%
controls:0.35%
cases:14.59%
controls:3.14%
cases:15.30%
controls:9.87%
75
804
934
9277
52
361
957
9720
16
39
993
10042
—
50
35
950
10024
143
308
837
9515
133
857
736
7828
Visual field defects
H53.4 [45557469]
H53.4 [45557469]
—
—
—
—
—
3.6e+00
2.6e+00
—
—
—
—
—
—
—
—
—
—
cases:2.55%
controls:0.07%
cases:2.30%
controls:0.17%
—
—
—
—
—
25
7
955
9816
20
15
849
8670
More than three and less than five hours
ZXE20 [2001311408]
ZXE20 [2001311408]
3.6e-01
1.8e+00
—
—
1.0e+50
3.1e+00
1.2e+00
cases:2.18%
controls:1.54%
cases:1.39%
controls:0.23%
—
—
—
—
cases:1.10%
controls:0.00%
cases:4.18%
controls:0.19%
cases:2.53%
controls:0.75%
22
155
987
9926
14
23
995
10058
—
—
11
0
989
10059
41
19
939
9804
22
65
847
8620
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
2.6e-02
4.2e-01
9.7e-01
3.1e+00
8.6e-01
4.6e-01
3.4e-01
cases:8.62%
controls:8.42%
cases:9.71%
controls:6.59%
cases:3.57%
controls:1.39%
cases:1.29%
controls:0.06%
cases:3.30%
controls:1.42%
cases:10.82%
controls:7.14%
cases:18.53%
controls:13.87%
87
849
922
9232
98
664
911
9417
36
140
973
9941
13
6
996
10075
33
143
967
9916
106
701
874
9122
161
1205
708
7480
Stroke/cerebrovascular accident
K90 [2002000617]
K90 [2002000617]
—
1.7e+00
—
—
—
2.8e+00
1.6e+00
—
—
cases:0.79%
controls:0.15%
—
—
—
—
—
—
cases:1.02%
controls:0.06%
cases:1.27%
controls:0.26%
—
8
15
1001
10066
—
—
—
10
6
970
9817
11
23
858
8662
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
4.0e-02
5.0e-01
1.6e+00
—
3.3e+00
1.9e+00
8.6e-01
cases:3.87%
controls:3.72%
cases:2.87%
controls:1.76%
cases:0.79%
controls:0.17%
—
—
cases:3.30%
controls:0.13%
cases:9.80%
controls:1.56%
cases:10.82%
controls:4.86%
39
375
970
9706
29
177
980
9904
8
17
1001
10064
—
33
13
967
10046
96
153
884
9670
94
422
775
8263
Perimetry
XCK00 [2001301380]
XCK00 [2001301380]
4.7e-01
1.6e+00
—
—
—
2.9e+00
1.5e+00
cases:1.09%
controls:0.68%
cases:1.09%
controls:0.22%
—
—
—
—
—
—
cases:4.08%
controls:0.24%
cases:2.76%
controls:0.64%
11
69
998
10012
11
22
998
10059
—
—
—
40
24
940
9799
24
56
845
8629
Subjective visual disturbances
H53.1 [45557467]
H53.1 [45557467]
1.2e+00
1.7e+00
—
—
—
2.0e+00
1.0e+00
cases:1.39%
controls:0.44%
cases:1.49%
controls:0.28%
—
—
—
—
—
—
cases:1.84%
controls:0.24%
cases:2.19%
controls:0.78%
14
44
995
10037
15
28
994
10053
—
—
—
18
24
962
9799
19
68
850
8617
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
5.7e-01
1.8e+00
2.9e+00
—
—
8.4e-01
1.2e+00
cases:2.87%
controls:1.65%
cases:2.58%
controls:0.43%
cases:0.89%
controls:0.05%
—
—
—
—
cases:1.12%
controls:0.49%
cases:3.80%
controls:1.19%
29
166
980
9915
26
43
983
10038
9
5
1000
10076
—
—
11
48
969
9775
33
103
836
8582
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
4.0e-01
—
—
1.0e+50
3.5e+00
2.3e+00
7.8e-01
cases:1.09%
controls:0.73%
—
—
—
—
cases:0.79%
controls:0.00%
cases:1.70%
controls:0.05%
cases:4.29%
controls:0.43%
cases:2.65%
controls:1.23%
11
74
998
10007
—
—
8
0
1001
10081
17
5
983
10054
42
42
938
9781
23
107
846
8578
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
4.0e-01
—
—
1.0e+50
3.5e+00
2.3e+00
7.8e-01
cases:1.09%
controls:0.73%
—
—
—
—
cases:0.79%
controls:0.00%
cases:1.70%
controls:0.05%
cases:4.08%
controls:0.41%
cases:2.65%
controls:1.23%
11
74
998
10007
—
—
8
0
1001
10081
17
5
983
10054
40
40
940
9783
23
107
846
8578
Bell palsy
G51.0 [45571815]
G51.0 [45571815]
—
2.3e+00
—
—
—
2.0e+00
1.5e+00
—
—
cases:0.69%
controls:0.07%
—
—
—
—
—
—
cases:0.92%
controls:0.12%
cases:1.15%
controls:0.26%
—
7
7
1002
10074
—
—
—
9
12
971
9811
10
23
859
8662
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
7.8e-02
2.2e-01
5.2e-01
3.6e+00
1.1e+00
6.8e-01
3.9e-01
cases:19.52%
controls:18.33%
cases:9.02%
controls:7.35%
cases:1.49%
controls:0.89%
cases:2.18%
controls:0.06%
cases:2.80%
controls:0.99%
cases:13.88%
controls:7.54%
cases:28.65%
controls:21.45%
197
1848
812
8233
91
741
918
9340
15
90
994
9991
22
6
987
10075
28
100
972
9959
136
741
844
9082
249
1863
620
6822
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
7.6e-03
5.1e-01
—
1.0e+50
3.5e+00
2.2e+00
6.4e-01
cases:1.19%
controls:1.18%
cases:0.69%
controls:0.42%
—
—
cases:0.79%
controls:0.00%
cases:2.20%
controls:0.07%
cases:4.69%
controls:0.56%
cases:3.45%
controls:1.84%
12
119
997
9962
7
42
1002
10039
—
8
0
1001
10081
22
7
978
10052
46
55
934
9768
30
160
839
8525
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
1.8e-02
6.0e-01
1.2e+00
—
2.1e+00
1.2e+00
5.2e-01
cases:8.03%
controls:7.90%
cases:7.53%
controls:4.30%
cases:2.28%
controls:0.69%
—
—
cases:5.70%
controls:0.74%
cases:13.37%
controls:4.41%
cases:16.92%
controls:10.77%
81
796
928
9285
76
433
933
9648
23
70
986
10011
—
57
74
943
9985
131
433
849
9390
147
935
722
7750
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
4.8e-01
1.1e+00
1.6e+00
—
1.4e+00
1.3e+00
1.1e+00
cases:7.04%
controls:4.46%
cases:3.67%
controls:1.20%
cases:0.99%
controls:0.20%
—
—
cases:0.70%
controls:0.18%
cases:4.29%
controls:1.23%
cases:8.29%
controls:2.91%
71
450
938
9631
37
121
972
9960
10
20
999
10061
—
7
18
993
10041
42
121
938
9702
72
253
797
8432
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
2.6e-01
6.8e-01
1.6e+00
—
2.0e+00
6.6e-01
6.0e-01
cases:5.45%
controls:4.26%
cases:4.56%
controls:2.37%
cases:1.19%
controls:0.24%
—
—
cases:1.50%
controls:0.20%
cases:4.18%
controls:2.20%
cases:11.16%
controls:6.44%
55
429
954
9652
46
239
963
9842
12
24
997
10057
—
15
20
985
10039
41
216
939
9607
97
559
772
8126
Audiology
64 [38004489]
64 [38004489]
6.7e-01
1.8e+00
2.2e+00
—
1.5e+00
9.1e-01
4.8e-01
cases:4.66%
controls:2.43%
cases:5.65%
controls:1.01%
cases:1.19%
controls:0.13%
—
—
cases:0.50%
controls:0.11%
cases:2.04%
controls:0.83%
cases:4.60%
controls:2.90%
47
245
962
9836
57
102
952
9979
12
13
997
10068
—
5
11
995
10048
20
82
960
9741
40
252
829
8433
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
-1.2e-02
4.2e-01
2.0e+00
—
2.2e+00
8.8e-01
5.2e-01
cases:3.87%
controls:3.91%
cases:2.58%
controls:1.71%
cases:0.99%
controls:0.14%
—
—
cases:1.20%
controls:0.14%
cases:3.27%
controls:1.38%
cases:6.79%
controls:4.13%
39
394
970
9687
26
172
983
9909
10
14
999
10067
—
12
14
988
10045
32
136
948
9687
59
359
810
8326
Complicated migraine
G43.3 [45576576]
G43.3 [45576576]
2.1e+00
2.0e+00
—
—
—
—
1.5e+00
cases:0.89%
controls:0.11%
cases:0.69%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.15%
controls:0.26%
9
11
1000
10070
7
10
1002
10071
—
—
—
—
10
23
859
8662
Paraesthesia of skin
R20.2 [45568120]
R20.2 [45568120]
8.2e-01
2.1e+00
—
—
—
1.8e+00
1.6e+00
cases:1.39%
controls:0.62%
cases:1.88%
controls:0.23%
—
—
—
—
—
—
cases:1.22%
controls:0.20%
cases:2.53%
controls:0.54%
14
62
995
10019
19
23
990
10058
—
—
—
12
20
968
9803
22
47
847
8638
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
-7.8e-02
1.0e+00
2.0e+00
—
1.8e+00
6.3e-01
2.1e-01
cases:5.55%
controls:5.97%
cases:7.83%
controls:2.97%
cases:2.28%
controls:0.32%
—
—
cases:2.10%
controls:0.36%
cases:5.61%
controls:3.07%
cases:11.74%
controls:9.73%
56
602
953
9479
79
299
930
9782
23
32
986
10049
—
21
36
979
10023
55
302
925
9521
102
845
767
7840
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
7.1e-02
8.8e-01
—
—
2.5e+00
1.3e+00
7.4e-01
cases:1.59%
controls:1.48%
cases:1.98%
controls:0.83%
—
—
—
—
cases:1.10%
controls:0.09%
cases:2.35%
controls:0.66%
cases:3.45%
controls:1.68%
16
149
993
9932
20
84
989
9997
—
—
11
9
989
10050
23
65
957
9758
30
146
839
8539
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
2.2e-01
9.6e-01
2.0e+00
—
2.0e+00
5.3e-01
3.9e-01
cases:4.66%
controls:3.76%
cases:5.65%
controls:2.23%
cases:2.18%
controls:0.30%
—
—
cases:1.70%
controls:0.23%
cases:4.08%
controls:2.44%
cases:11.62%
controls:8.19%
47
379
962
9702
57
225
952
9856
22
30
987
10051
—
17
23
983
10036
40
240
940
9583
101
711
768
7974
Lumbar puncture
TAB00 [2001300538]
TAB00 [2001300538]
1.4e-01
2.4e+00
—
1.0e+50
—
2.9e+00
1.1e+00
cases:0.59%
controls:0.52%
cases:1.09%
controls:0.10%
—
—
cases:0.59%
controls:0.00%
—
—
cases:1.33%
controls:0.07%
cases:0.92%
controls:0.32%
6
52
1003
10029
11
10
998
10071
—
6
0
1003
10081
—
13
7
967
9816
8
28
861
8657
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
1.0e-01
5.2e-01
1.1e+00
—
2.0e+00
1.2e+00
4.6e-01
cases:9.51%
controls:8.67%
cases:8.03%
controls:4.94%
cases:2.58%
controls:0.84%
—
—
cases:6.00%
controls:0.87%
cases:14.69%
controls:5.09%
cases:19.22%
controls:13.07%
96
874
913
9207
81
498
928
9583
26
85
983
9996
—
60
88
940
9971
144
500
836
9323
167
1135
702
7550
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
NA1BG [2001306990]
1.4e-01
2.0e+00
—
—
—
1.8e+00
1.5e+00
cases:0.69%
controls:0.61%
cases:0.69%
controls:0.10%
—
—
—
—
—
—
cases:0.71%
controls:0.12%
cases:2.19%
controls:0.48%
7
61
1002
10020
7
10
1002
10071
—
—
—
7
12
973
9811
19
42
850
8643
Paediatric neurology
421 [44777781]
421 [44777781]
6.7e-01
1.8e+00
—
—
—
1.7e+00
1.7e+00
cases:0.69%
controls:0.36%
cases:1.19%
controls:0.21%
—
—
—
—
—
—
cases:1.12%
controls:0.20%
cases:1.38%
controls:0.25%
7
36
1002
10045
12
21
997
10060
—
—
—
11
20
969
9803
12
22
857
8663
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
-4.8e-02
2.1e-01
9.6e-01
2.9e+00
8.9e-01
3.8e-01
1.1e-01
cases:38.65%
controls:39.80%
cases:43.21%
controls:38.08%
cases:25.47%
controls:11.62%
cases:10.80%
controls:0.63%
cases:23.60%
controls:11.23%
cases:48.78%
controls:39.42%
cases:61.57%
controls:59.01%
390
4012
619
6069
436
3839
573
6242
257
1171
752
8910
109
64
900
10017
236
1130
764
8929
478
3872
502
5951
535
5125
334
3560
Otolaryngology
4 [38004449]
4 [38004449]
1.9e-01
1.2e+00
1.2e+00
—
1.4e+00
8.7e-01
5.3e-01
cases:12.69%
controls:10.68%
cases:11.69%
controls:3.72%
cases:2.08%
controls:0.66%
—
—
cases:2.40%
controls:0.62%
cases:8.37%
controls:3.70%
cases:17.84%
controls:11.33%
128
1077
881
9004
118
375
891
9706
21
67
988
10014
—
24
62
976
9997
82
363
898
9460
155
984
714
7701
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
6.0e-01
1.0e+00
—
—
2.7e+00
1.6e+00
7.3e-01
cases:1.39%
controls:0.76%
cases:1.09%
controls:0.40%
—
—
—
—
cases:1.50%
controls:0.10%
cases:3.06%
controls:0.66%
cases:3.91%
controls:1.92%
14
77
995
10004
11
40
998
10041
—
—
15
10
985
10049
30
65
950
9758
34
167
835
8518
Ophthalmology
18 [38004463]
18 [38004463]
8.6e-03
7.1e-01
1.1e+00
1.9e+00
1.4e+00
1.2e+00
6.1e-01
cases:13.08%
controls:12.98%
cases:11.40%
controls:5.95%
cases:3.47%
controls:1.18%
cases:0.59%
controls:0.09%
cases:4.00%
controls:1.01%
cases:17.76%
controls:6.26%
cases:26.01%
controls:16.06%
132
1309
877
8772
115
600
894
9481
35
119
974
9962
6
9
1003
10072
40
102
960
9957
174
615
806
9208
226
1395
643
7290
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.2 [45591172]
G40.2 [45591172]
1.6e+00
2.3e+00
—
—
—
—
2.6e+00
cases:0.50%
controls:0.10%
cases:0.69%
controls:0.07%
—
—
—
—
—
—
—
—
cases:2.07%
controls:0.15%
5
10
1004
10071
7
7
1002
10074
—
—
—
—
18
13
851
8672
Inpatient Visit
IP [9201]
IP [9201]
1.8e-01
2.7e-01
—
1.0e+50
2.5e+00
1.8e+00
6.7e-01
cases:5.65%
controls:4.77%
cases:2.87%
controls:2.21%
—
—
cases:1.49%
controls:0.00%
cases:3.30%
controls:0.29%
cases:11.73%
controls:2.25%
cases:12.31%
controls:6.69%
57
481
952
9600
29
223
980
9858
—
15
0
994
10081
33
29
967
10030
115
221
865
9602
107
581
762
8104
Haemangioma, any site
D18.0 [45586089]
D18.0 [45586089]
2.1e+00
—
1.0e+50
—
1.0e+50
—
2.7e+00
cases:1.09%
controls:0.13%
—
—
cases:0.59%
controls:0.00%
—
—
cases:0.60%
controls:0.00%
—
—
cases:2.42%
controls:0.17%
11
13
998
10068
—
6
0
1003
10081
—
6
0
994
10059
—
21
15
848
8670
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
4.6e-01
7.9e-01
5.8e-01
5.7e-01
4.4e-01
1.3e+00
1.7e+00
cases:95.94%
controls:93.73%
cases:91.87%
controls:83.74%
cases:58.47%
controls:44.13%
cases:4.06%
controls:2.34%
cases:55.60%
controls:44.63%
cases:95.10%
controls:84.38%
cases:99.19%
controls:95.75%
968
9449
41
632
927
8442
82
1639
590
4449
419
5632
41
236
968
9845
556
4489
444
5570
932
8289
48
1534
862
8316
7
369
lacosamide; oral, parenteral
N03AX18 [21604440]
N03AX18 [21604440]
—
1.9e+00
—
—
—
2.5e+00
2.2e+00
—
—
cases:0.59%
controls:0.09%
—
—
—
—
—
—
cases:1.12%
controls:0.09%
cases:1.61%
controls:0.17%
—
6
9
1003
10072
—
—
—
11
9
969
9814
14
15
855
8670
Other healthcare associate professional
Z3229 [2001311561]
Z3229 [2001311561]
2.5e-01
1.5e+00
—
—
—
2.1e+00
1.2e+00
cases:1.29%
controls:1.00%
cases:1.19%
controls:0.27%
—
—
—
—
—
—
cases:1.84%
controls:0.23%
cases:2.19%
controls:0.69%
13
101
996
9980
12
27
997
10054
—
—
—
18
23
962
9800
19
60
850
8625
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
26454-9 [3027475]
4.4e-01
2.4e+00
—
—
1.0e+50
2.2e+00
8.3e-02
cases:0.69%
controls:0.45%
cases:0.99%
controls:0.09%
—
—
—
—
cases:0.60%
controls:0.00%
cases:1.43%
controls:0.16%
cases:0.58%
controls:0.53%
7
45
1002
10036
10
9
999
10072
—
—
6
0
994
10059
14
16
966
9807
5
46
864
8639
Differential panel - Cerebral spinal fluid
29584-0 [3016018]
29584-0 [3016018]
—
2.2e+00
—
—
—
2.4e+00
8.2e-01
—
—
cases:0.59%
controls:0.07%
—
—
—
—
—
—
cases:0.92%
controls:0.08%
cases:0.58%
controls:0.25%
—
6
7
1003
10074
—
—
—
9
8
971
9815
5
22
864
8663
Tension-type headache
G44.2 [45581495]
G44.2 [45581495]
4.9e-01
1.1e+00
2.2e+00
—
-1.0e+50
1.0e+00
1.3e+00
cases:2.78%
controls:1.73%
cases:1.68%
controls:0.55%
cases:0.59%
controls:0.07%
—
—
cases:0.00%
controls:0.06%
cases:1.33%
controls:0.47%
cases:5.18%
controls:1.52%
28
174
981
9907
17
55
992
10026
6
7
1003
10074
—
0
6
1000
10053
13
46
967
9777
45
132
824
8553
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
1.0e-01
9.1e-01
1.0e+00
—
2.6e+00
1.1e+00
4.7e-01
cases:2.68%
controls:2.42%
cases:3.27%
controls:1.35%
cases:0.50%
controls:0.18%
—
—
cases:2.20%
controls:0.17%
cases:2.96%
controls:1.05%
cases:5.06%
controls:3.22%
27
244
982
9837
33
136
976
9945
5
18
1004
10063
—
22
17
978
10042
29
103
951
9720
44
280
825
8405
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
26465-5 [3016543]
4.4e-01
2.4e+00
—
—
1.0e+50
2.1e+00
8.3e-02
cases:0.69%
controls:0.45%
cases:0.99%
controls:0.09%
—
—
—
—
cases:0.60%
controls:0.00%
cases:1.33%
controls:0.16%
cases:0.58%
controls:0.53%
7
45
1002
10036
10
9
999
10072
—
—
6
0
994
10059
13
16
967
9807
5
46
864
8639
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
1.9e-02
1.7e-01
4.9e-01
3.3e+00
4.7e-01
2.7e-01
2.5e-01
cases:61.25%
controls:60.81%
cases:58.28%
controls:53.97%
cases:31.81%
controls:22.22%
cases:26.86%
controls:1.36%
cases:31.10%
controls:21.99%
cases:63.57%
controls:57.09%
cases:80.21%
controls:75.90%
618
6130
391
3951
588
5441
421
4640
321
2240
688
7841
271
137
738
9944
311
2212
689
7847
623
5608
357
4215
697
6592
172
2093
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
2.7e-01
6.7e-01
1.5e+00
—
1.8e+00
5.4e-01
5.5e-01
cases:5.65%
controls:4.36%
cases:4.96%
controls:2.59%
cases:1.29%
controls:0.29%
—
—
cases:1.50%
controls:0.26%
cases:4.08%
controls:2.41%
cases:11.39%
controls:6.90%
57
440
952
9641
50
261
959
9820
13
29
996
10052
—
15
26
985
10033
40
237
940
9586
99
599
770
8086
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
-5.0e-02
6.6e-01
—
1.0e+50
3.1e+00
1.4e+00
5.2e-01
cases:0.59%
controls:0.62%
cases:0.50%
controls:0.26%
—
—
cases:0.50%
controls:0.00%
cases:1.10%
controls:0.05%
cases:1.22%
controls:0.32%
cases:1.84%
controls:1.11%
6
63
1003
10018
5
26
1004
10055
—
5
0
1004
10081
11
5
989
10054
12
31
968
9792
16
96
853
8589
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
182 [2001600181]
182 [2001600181]
2.1e+00
—
—
—
—
—
2.4e+00
cases:0.79%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.96%
controls:0.18%
8
10
1001
10071
—
—
—
—
—
17
16
852
8669
Rehabilitation Hospital
283X00000X [38004285]
283X00000X [38004285]
—
—
—
—
—
2.4e+00
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.08%
cases:1.73%
controls:0.23%
—
—
—
—
—
9
8
971
9815
15
20
854
8665
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
34563-7 [3044290]
2.7e-01
2.3e+00
—
—
1.0e+50
2.1e+00
4.9e-01
cases:0.59%
controls:0.46%
cases:0.89%
controls:0.09%
—
—
—
—
cases:0.70%
controls:0.00%
cases:1.12%
controls:0.13%
cases:0.69%
controls:0.43%
6
46
1003
10035
9
9
1000
10072
—
—
7
0
993
10059
11
13
969
9810
6
37
863
8648
Cerebral very extensive angiography with X-ray
PA2CC [2001300227]
PA2CC [2001300227]
—
—
—
1.0e+50
1.0e+50
—
4.4e+00
—
—
—
—
—
—
cases:4.56%
controls:0.00%
cases:2.20%
controls:0.00%
—
—
cases:4.60%
controls:0.06%
—
—
—
46
0
963
10081
22
0
978
10059
—
40
5
829
8680
Internal Medicine
11 [38004456]
11 [38004456]
1.4e-01
6.1e-01
1.3e+00
—
1.2e+00
7.4e-01
5.9e-01
cases:22.50%
controls:20.15%
cases:13.38%
controls:7.78%
cases:4.26%
controls:1.22%
—
—
cases:3.60%
controls:1.10%
cases:13.78%
controls:7.10%
cases:28.42%
controls:18.09%
227
2031
782
8050
135
784
874
9297
43
123
966
9958
—
36
111
964
9948
135
697
845
9126
247
1571
622
7114
Paralysis/weakness
N18 [2002000729]
N18 [2002000729]
—
—
—
—
—
2.4e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.08%
cases:0.92%
controls:0.14%
—
—
—
—
—
9
8
971
9815
8
12
861
8673
Sequelae of subarachnoid haemorrhage
I69.0 [45543193]
I69.0 [45543193]
—
2.3e+00
—
—
—
—
2.0e+00
—
—
cases:0.59%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.18%
—
6
6
1003
10075
—
—
—
—
12
16
857
8669
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-9.8e-01
-5.9e-01
-7.8e-01
—
—
3.1e+00
2.7e+00
cases:12.59%
controls:27.65%
cases:5.55%
controls:9.58%
cases:0.50%
controls:1.07%
—
—
—
—
cases:8.98%
controls:0.43%
cases:15.88%
controls:1.20%
127
2787
882
7294
56
966
953
9115
5
108
1004
9973
—
—
88
42
892
9781
138
104
731
8581
Hypothyroidism, unspecified
E03.9 [45537945]
E03.9 [45537945]
-1.1e-01
4.4e-01
2.3e+00
1.0e+50
2.0e+00
6.8e-01
3.1e-02
cases:1.68%
controls:1.87%
cases:1.29%
controls:0.83%
cases:0.59%
controls:0.06%
cases:0.99%
controls:0.00%
cases:0.80%
controls:0.11%
cases:1.53%
controls:0.78%
cases:2.65%
controls:2.57%
17
189
992
9892
13
84
996
9997
6
6
1003
10075
10
0
999
10081
8
11
992
10048
15
77
965
9746
23
223
846
8462
Right side
ZXA00 [2001311346]
ZXA00 [2001311346]
1.5e-01
7.0e-01
—
1.0e+50
2.1e+00
1.5e+00
6.4e-01
cases:4.16%
controls:3.59%
cases:1.78%
controls:0.89%
—
—
cases:0.79%
controls:0.00%
cases:0.80%
controls:0.10%
cases:2.86%
controls:0.64%
cases:5.06%
controls:2.73%
42
362
967
9719
18
90
991
9991
—
8
0
1001
10081
8
10
992
10049
28
63
952
9760
44
237
825
8448
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
6.4e-01
5.1e-01
2.1e+00
1.0e+50
2.6e+00
1.6e+00
5.4e-01
cases:1.78%
controls:0.95%
cases:1.09%
controls:0.65%
cases:0.50%
controls:0.06%
cases:0.79%
controls:0.00%
cases:1.60%
controls:0.12%
cases:3.78%
controls:0.77%
cases:3.57%
controls:2.11%
18
96
991
9985
11
66
998
10015
5
6
1004
10075
8
0
1001
10081
16
12
984
10047
37
76
943
9747
31
183
838
8502
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
2880-3 [3019473]
1.6e-02
2.3e+00
—
—
1.0e+50
1.9e+00
4.0e-02
cases:0.59%
controls:0.59%
cases:1.19%
controls:0.12%
—
—
—
—
cases:0.70%
controls:0.00%
cases:1.22%
controls:0.18%
cases:0.58%
controls:0.55%
6
59
1003
10022
12
12
997
10069
—
—
7
0
993
10059
12
18
968
9805
5
48
864
8637
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
1.7e-01
6.4e-01
1.3e+00
—
1.7e+00
5.0e-01
4.9e-01
cases:5.85%
controls:4.97%
cases:5.35%
controls:2.91%
cases:1.29%
controls:0.34%
—
—
cases:1.60%
controls:0.29%
cases:4.59%
controls:2.84%
cases:12.77%
controls:8.24%
59
501
950
9580
54
293
955
9788
13
34
996
10047
—
16
29
984
10030
45
279
935
9544
111
716
758
7969
Left side
ZXA05 [2001311347]
ZXA05 [2001311347]
1.2e-01
6.8e-01
—
—
2.0e+00
1.3e+00
7.8e-01
cases:3.47%
controls:3.09%
cases:1.59%
controls:0.81%
—
—
—
—
cases:0.90%
controls:0.12%
cases:2.55%
controls:0.69%
cases:5.29%
controls:2.50%
35
312
974
9769
16
82
993
9999
—
—
9
12
991
10047
25
68
955
9755
46
217
823
8468
Dizziness and giddiness
R42 [45568132]
R42 [45568132]
4.6e-01
1.1e+00
2.3e+00
1.0e+50
1.8e+00
7.6e-01
7.2e-01
cases:4.16%
controls:2.66%
cases:2.97%
controls:1.03%
cases:1.09%
controls:0.11%
cases:0.59%
controls:0.00%
cases:0.60%
controls:0.10%
cases:1.94%
controls:0.92%
cases:6.56%
controls:3.32%
42
268
967
9813
30
104
979
9977
11
11
998
10070
6
0
1003
10081
6
10
994
10049
19
90
961
9733
57
288
812
8397
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
14744-7 [3020044]
-9.0e-04
2.2e+00
—
—
—
1.9e+00
—
cases:0.50%
controls:0.50%
cases:0.99%
controls:0.11%
—
—
—
—
—
—
cases:1.12%
controls:0.17%
—
—
5
50
1004
10031
10
11
999
10070
—
—
—
11
17
969
9806
—
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
-2.1e-02
6.6e-01
1.6e+00
1.0e+50
2.5e+00
1.6e+00
4.2e-01
cases:1.49%
controls:1.52%
cases:1.49%
controls:0.77%
cases:0.50%
controls:0.10%
cases:0.59%
controls:0.00%
cases:1.70%
controls:0.14%
cases:4.49%
controls:0.97%
cases:4.37%
controls:2.91%
15
153
994
9928
15
78
994
10003
5
10
1004
10071
6
0
1003
10081
17
14
983
10045
44
95
936
9728
38
253
831
8432
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
5.3e-01
9.9e-01
8.7e-01
1.0e+50
1.2e+00
1.5e+00
1.0e+00
cases:9.71%
controls:5.93%
cases:4.16%
controls:1.59%
cases:0.50%
controls:0.21%
cases:1.78%
controls:0.00%
cases:0.90%
controls:0.27%
cases:6.22%
controls:1.43%
cases:9.55%
controls:3.67%
98
598
911
9483
42
160
967
9921
5
21
1004
10060
18
0
991
10081
9
27
991
10032
61
140
919
9683
83
319
786
8366
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
2.0e-01
6.0e-01
1.2e+00
—
1.8e+00
5.0e-01
4.9e-01
cases:7.43%
controls:6.19%
cases:5.85%
controls:3.30%
cases:1.29%
controls:0.40%
—
—
cases:1.70%
controls:0.30%
cases:5.51%
controls:3.41%
cases:13.81%
controls:8.93%
75
624
934
9457
59
333
950
9748
13
40
996
10041
—
17
30
983
10029
54
335
926
9488
120
776
749
7909
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
N03AG01 [21604422]
4.7e-01
7.1e-01
1.3e+00
—
8.5e-01
1.3e+00
1.3e+00
cases:1.88%
controls:1.19%
cases:1.98%
controls:0.98%
cases:1.39%
controls:0.38%
—
—
cases:0.60%
controls:0.26%
cases:3.27%
controls:0.89%
cases:4.03%
controls:1.08%
19
120
990
9961
20
99
989
9982
14
38
995
10043
—
6
26
994
10033
32
87
948
9736
35
94
834
8591
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
3209-4 [3019250]
6.0e-01
1.9e+00
—
—
—
2.1e+00
7.7e-01
cases:0.79%
controls:0.44%
cases:1.78%
controls:0.28%
—
—
—
—
—
—
cases:1.02%
controls:0.13%
cases:1.38%
controls:0.64%
8
44
1001
10037
18
28
991
10053
—
—
—
10
13
970
9810
12
56
857
8629
Medical Oncology
90 [38004507]
90 [38004507]
2.7e-01
2.6e-01
5.6e-01
2.1e+00
5.0e-01
9.0e-01
8.8e-01
cases:4.66%
controls:3.59%
cases:3.27%
controls:2.55%
cases:1.49%
controls:0.85%
cases:0.89%
controls:0.11%
cases:1.70%
controls:1.03%
cases:6.33%
controls:2.68%
cases:9.21%
controls:4.02%
47
362
962
9719
33
257
976
9824
15
86
994
9995
9
11
1000
10070
17
104
983
9955
62
263
918
9560
80
349
789
8336
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
3255-7 [3016407]
9.2e-01
2.0e+00
—
—
—
1.9e+00
9.6e-01
cases:0.89%
controls:0.36%
cases:1.59%
controls:0.23%
—
—
—
—
—
—
cases:0.92%
controls:0.14%
cases:1.50%
controls:0.58%
9
36
1000
10045
16
23
993
10058
—
—
—
9
14
971
9809
13
50
856
8635
EKG study
11524-6 [3013512]
11524-6 [3013512]
-9.9e-03
5.5e-01
1.1e+00
—
1.5e+00
6.1e-01
1.9e-01
cases:5.85%
controls:5.90%
cases:5.35%
controls:3.14%
cases:1.39%
controls:0.45%
—
—
cases:1.70%
controls:0.39%
cases:5.82%
controls:3.26%
cases:11.16%
controls:9.45%
59
595
950
9486
54
317
955
9764
14
45
995
10036
—
17
39
983
10020
57
320
923
9503
97
821
772
7864
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
H90.4 [45572067]
H90.4 [45572067]
1.5e+00
2.3e+00
—
—
—
—
—
cases:1.39%
controls:0.32%
cases:0.99%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
14
32
995
10049
10
10
999
10071
—
—
—
—
—
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
1.4e-01
9.6e-01
—
1.0e+50
—
1.7e+00
1.1e+00
cases:2.78%
controls:2.43%
cases:2.08%
controls:0.80%
—
—
cases:0.89%
controls:0.00%
—
—
cases:3.37%
controls:0.64%
cases:5.41%
controls:1.91%
28
245
981
9836
21
81
988
10000
—
9
0
1000
10081
—
33
63
947
9760
47
166
822
8519
Social worker
Z2446 [2001311559]
Z2446 [2001311559]
4.8e-01
—
-1.0e+50
—
2.3e+00
1.9e+00
1.8e+00
cases:1.29%
controls:0.80%
—
—
cases:0.00%
controls:0.05%
—
—
cases:0.50%
controls:0.05%
cases:1.12%
controls:0.16%
cases:2.53%
controls:0.44%
13
81
996
10000
—
0
5
1009
10076
—
5
5
995
10054
11
16
969
9807
22
38
847
8647
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
2.6e-02
3.1e-01
1.2e+00
—
1.5e+00
7.3e-01
2.8e-01
cases:15.36%
controls:15.03%
cases:10.80%
controls:8.12%
cases:3.17%
controls:0.97%
—
—
cases:4.00%
controls:0.94%
cases:15.82%
controls:8.28%
cases:28.19%
controls:22.86%
155
1515
854
8566
109
819
900
9262
32
98
977
9983
—
40
95
960
9964
155
813
825
9010
245
1985
624
6700
Skin texture symptom/complaint
S21 [2002000986]
S21 [2002000986]
-3.2e-01
5.9e-01
2.5e+00
—
—
1.1e+00
5.2e-01
cases:1.19%
controls:1.63%
cases:0.89%
controls:0.50%
cases:0.59%
controls:0.05%
—
—
—
—
cases:1.43%
controls:0.46%
cases:3.57%
controls:2.15%
12
164
997
9917
9
50
1000
10031
6
5
1003
10076
—
—
14
45
966
9778
31
187
838
8498
Visual field testing with Octopus automated perimetry
CS444 [2001301477]
CS444 [2001301477]
—
1.1e+00
—
—
—
2.2e+00
1.4e+00
—
—
cases:0.59%
controls:0.21%
—
—
—
—
—
—
cases:1.12%
controls:0.12%
cases:1.73%
controls:0.44%
—
6
21
1003
10060
—
—
—
11
12
969
9811
15
38
854
8647
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
2.2e-01
6.1e-01
1.2e+00
—
1.4e+00
4.2e-01
4.3e-01
cases:6.94%
controls:5.66%
cases:6.14%
controls:3.44%
cases:1.39%
controls:0.43%
—
—
cases:1.60%
controls:0.41%
cases:5.41%
controls:3.62%
cases:14.50%
controls:9.93%
70
571
939
9510
62
347
947
9734
14
43
995
10038
—
16
41
984
10018
53
356
927
9467
126
862
743
7823
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
-1.9e-02
2.6e-01
6.7e-01
1.9e+00
8.1e-01
2.2e-01
1.8e-01
cases:29.83%
controls:30.23%
cases:28.05%
controls:23.06%
cases:8.23%
controls:4.37%
cases:1.19%
controls:0.19%
cases:9.10%
controls:4.27%
cases:29.39%
controls:24.96%
cases:52.01%
controls:47.40%
301
3047
708
7034
283
2325
726
7756
83
441
926
9640
12
19
997
10062
91
430
909
9629
288
2452
692
7371
452
4117
417
4568
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
27811-9 [3000515]
6.3e-01
1.7e+00
—
—
—
1.9e+00
7.7e-01
cases:0.89%
controls:0.48%
cases:1.49%
controls:0.29%
—
—
—
—
—
—
cases:1.12%
controls:0.16%
cases:1.38%
controls:0.64%
9
48
1000
10033
15
29
994
10052
—
—
—
11
16
969
9807
12
56
857
8629
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
-3.2e-02
5.6e-01
1.5e+00
—
2.1e+00
5.5e-01
5.2e-01
cases:1.29%
controls:1.33%
cases:1.59%
controls:0.91%
cases:0.89%
controls:0.20%
—
—
cases:1.70%
controls:0.22%
cases:1.73%
controls:1.01%
cases:3.45%
controls:2.07%
13
134
996
9947
16
92
993
9989
9
20
1000
10061
—
17
22
983
10037
17
99
963
9724
30
180
839
8505
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
6.6e-01
1.0e+00
9.2e-01
—
1.0e+00
9.5e-01
9.5e-01
cases:4.86%
controls:2.56%
cases:3.47%
controls:1.29%
cases:0.89%
controls:0.36%
—
—
cases:1.20%
controls:0.43%
cases:3.67%
controls:1.46%
cases:6.10%
controls:2.45%
49
258
960
9823
35
130
974
9951
9
36
1000
10045
—
12
43
988
10016
36
143
944
9680
53
213
816
8472
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
2.3e-01
4.9e-01
8.3e-01
—
2.1e+00
9.2e-01
5.9e-01
cases:9.02%
controls:7.31%
cases:4.36%
controls:2.71%
cases:0.79%
controls:0.35%
—
—
cases:2.50%
controls:0.33%
cases:6.12%
controls:2.52%
cases:13.92%
controls:8.26%
91
737
918
9344
44
273
965
9808
8
35
1001
10046
—
25
33
975
10026
60
248
920
9575
121
717
748
7968
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
3.0e-01
3.0e-01
1.9e+00
1.0e+50
1.6e+00
6.0e-01
3.4e-01
cases:3.67%
controls:2.75%
cases:1.98%
controls:1.48%
cases:0.99%
controls:0.15%
cases:0.79%
controls:0.00%
cases:1.00%
controls:0.20%
cases:2.86%
controls:1.59%
cases:6.67%
controls:4.85%
37
277
972
9804
20
149
989
9932
10
15
999
10066
8
0
1001
10081
10
20
990
10039
28
156
952
9667
58
421
811
8264
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
1.3e-01
5.6e-01
1.2e+00
—
1.4e+00
3.9e-01
4.0e-01
cases:5.55%
controls:4.89%
cases:4.96%
controls:2.89%
cases:1.68%
controls:0.53%
—
—
cases:1.70%
controls:0.44%
cases:4.18%
controls:2.86%
cases:10.70%
controls:7.40%
56
493
953
9588
50
291
959
9790
17
53
992
10028
—
17
44
983
10015
41
281
939
9542
93
643
776
8042
Headache
R51 [45558474]
R51 [45558474]
6.7e-01
2.4e+00
1.0e+50
—
—
—
1.1e+00
cases:0.79%
controls:0.41%
cases:1.29%
controls:0.12%
cases:0.50%
controls:0.00%
—
—
—
—
—
—
cases:1.96%
controls:0.66%
8
41
1001
10040
13
12
996
10069
5
0
1004
10081
—
—
—
17
57
852
8628
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
R41.8 [45534452]
—
1.8e+00
—
1.0e+50
—
1.7e+00
7.6e-01
—
—
cases:1.78%
controls:0.30%
—
—
cases:0.79%
controls:0.00%
—
—
cases:1.63%
controls:0.32%
cases:2.19%
controls:1.04%
—
18
30
991
10051
—
8
0
1001
10081
—
16
31
964
9792
19
90
850
8595
clonazepam; oral, parenteral
N03AE01 [21604415]
N03AE01 [21604415]
5.6e-01
9.9e-01
1.3e+00
—
—
1.2e+00
1.2e+00
cases:1.78%
controls:1.03%
cases:1.68%
controls:0.63%
cases:0.50%
controls:0.14%
—
—
—
—
cases:2.14%
controls:0.63%
cases:2.99%
controls:0.91%
18
104
991
9977
17
64
992
10017
5
14
1004
10067
—
—
21
62
959
9761
26
79
843
8606
Gas and Carbon monoxide and Electrolytes panel - Arterial blood
93685-6 [1001509]
93685-6 [1001509]
—
—
—
1.0e+50
—
1.0e+50
3.4e+00
—
—
—
—
—
—
cases:0.50%
controls:0.00%
—
—
cases:5.41%
controls:0.00%
cases:2.07%
controls:0.07%
—
—
—
5
0
1004
10081
—
53
0
927
9823
18
6
851
8679
Thrombin time
3243-3 [3036489]
3243-3 [3036489]
5.0e-01
1.8e+00
—
1.0e+50
—
1.6e+00
8.2e-01
cases:0.89%
controls:0.55%
cases:2.08%
controls:0.34%
—
—
cases:0.59%
controls:0.00%
—
—
cases:1.12%
controls:0.23%
cases:1.61%
controls:0.71%
9
55
1000
10026
21
34
988
10047
—
6
0
1003
10081
—
11
23
969
9800
14
62
855
8623
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
-6.5e-03
3.7e-01
1.2e+00
—
1.8e+00
9.6e-01
6.1e-01
cases:3.67%
controls:3.69%
cases:2.58%
controls:1.79%
cases:0.69%
controls:0.21%
—
—
cases:0.80%
controls:0.13%
cases:3.47%
controls:1.35%
cases:7.48%
controls:4.21%
37
372
972
9709
26
180
983
9901
7
21
1002
10060
—
8
13
992
10046
34
133
946
9690
65
366
804
8319
Abdominal X-ray examination without contrast
JN3AA [2001305553]
JN3AA [2001305553]
8.2e-01
2.1e+00
—
—
—
—
1.3e+00
cases:0.50%
controls:0.22%
cases:0.69%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.33%
5
22
1004
10059
7
9
1002
10072
—
—
—
—
11
29
858
8656
Monitored bed care
WX892 [2001310850]
WX892 [2001310850]
3.4e-01
9.9e-01
—
—
—
1.9e+00
1.5e+00
cases:0.89%
controls:0.63%
cases:0.69%
controls:0.26%
—
—
—
—
—
—
cases:1.43%
controls:0.21%
cases:2.42%
controls:0.56%
9
64
1000
10017
7
26
1002
10055
—
—
—
14
21
966
9802
21
49
848
8636
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
1.4e-01
4.0e-01
9.9e-01
—
1.2e+00
3.9e-01
3.5e-01
cases:14.97%
controls:13.25%
cases:10.11%
controls:7.02%
cases:1.98%
controls:0.74%
—
—
cases:2.90%
controls:0.88%
cases:10.00%
controls:7.02%
cases:23.94%
controls:18.15%
151
1336
858
8745
102
708
907
9373
20
75
989
10006
—
29
89
971
9970
98
690
882
9133
208
1576
661
7109
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
1.1e-01
8.1e-01
1.3e+00
—
1.1e+00
7.9e-01
4.3e-01
cases:8.23%
controls:7.43%
cases:6.34%
controls:2.92%
cases:1.59%
controls:0.45%
—
—
cases:0.80%
controls:0.27%
cases:5.51%
controls:2.59%
cases:12.20%
controls:8.29%
83
749
926
9332
64
294
945
9787
16
45
993
10036
—
8
27
992
10032
54
254
926
9569
106
720
763
7965
Simple partial seizures with secondary generalization
G40.12 [2000502137]
G40.12 [2000502137]
—
—
—
—
—
3.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.33%
controls:0.05%
—
—
—
—
—
—
—
13
5
967
9818
—
Intracerebral haemorrhage in hemisphere, subcortical
I61.0 [45605803]
I61.0 [45605803]
—
—
1.0e+50
1.0e+50
1.0e+50
—
3.3e+00
—
—
—
—
cases:0.89%
controls:0.00%
cases:1.59%
controls:0.00%
cases:1.00%
controls:0.00%
—
—
cases:1.50%
controls:0.06%
—
—
9
0
1000
10081
16
0
993
10081
10
0
990
10059
—
13
5
856
8680
Extensive CT angiography of brain
PA2BD [2001300226]
PA2BD [2001300226]
—
—
1.0e+50
1.0e+50
—
—
3.3e+00
—
—
—
—
cases:0.99%
controls:0.00%
cases:1.88%
controls:0.00%
—
—
—
—
cases:1.50%
controls:0.06%
—
—
10
0
999
10081
19
0
990
10081
—
—
13
5
856
8680
pH of Capillary blood
2745-8 [3009343]
2745-8 [3009343]
1.4e-01
5.8e-01
—
—
2.5e+00
1.1e+00
8.0e-01
cases:1.09%
controls:0.95%
cases:0.79%
controls:0.45%
—
—
—
—
cases:0.70%
controls:0.06%
cases:1.22%
controls:0.43%
cases:2.88%
controls:1.31%
11
96
998
9985
8
45
1001
10036
—
—
7
6
993
10053
12
42
968
9781
25
114
844
8571
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
3216-9 [3020427]
—
1.9e+00
—
—
—
1.4e+00
3.2e-01
—
—
cases:0.89%
controls:0.14%
—
—
—
—
—
—
cases:1.02%
controls:0.25%
cases:0.81%
controls:0.59%
—
9
14
1000
10067
—
—
—
10
25
970
9798
7
51
862
8634
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2020-6 [3023024]
1.4e-01
5.6e-01
—
—
2.5e+00
1.0e+00
7.8e-01
cases:1.09%
controls:0.95%
cases:0.79%
controls:0.46%
—
—
—
—
cases:0.70%
controls:0.06%
cases:1.22%
controls:0.44%
cases:2.88%
controls:1.34%
11
96
998
9985
8
46
1001
10035
—
—
7
6
993
10053
12
43
968
9780
25
116
844
8569
Syncope and collapse
R55 [45568141]
R55 [45568141]
3.7e-01
1.8e+00
—
—
—
1.5e+00
6.9e-01
cases:1.59%
controls:1.10%
cases:1.39%
controls:0.24%
—
—
—
—
—
—
cases:1.12%
controls:0.26%
cases:2.19%
controls:1.11%
16
111
993
9970
14
24
995
10057
—
—
—
11
26
969
9797
19
96
850
8589
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
ZXE11 [2001311402]
8.1e-01
—
—
—
—
1.8e+00
1.4e+00
cases:1.59%
controls:0.71%
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.21%
cases:1.15%
controls:0.28%
16
72
993
10009
—
—
—
—
12
21
968
9802
10
24
859
8661
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
OMOP4822000 [32411]
2.5e-01
1.3e+00
—
—
—
1.7e+00
1.5e+00
cases:0.99%
controls:0.77%
cases:0.89%
controls:0.25%
—
—
—
—
—
—
cases:0.92%
controls:0.17%
cases:2.19%
controls:0.50%
10
78
999
10003
9
25
1000
10056
—
—
—
9
17
971
9806
19
43
850
8642
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
9.5e-02
1.1e+00
2.0e+00
—
—
5.9e-01
3.8e-01
cases:2.68%
controls:2.44%
cases:2.58%
controls:0.83%
cases:0.59%
controls:0.08%
—
—
—
—
cases:1.53%
controls:0.86%
cases:3.91%
controls:2.72%
27
246
982
9835
26
84
983
9997
6
8
1003
10073
—
—
15
84
965
9739
34
236
835
8449
Extirpation of intracranial lesion
AAB00 [2001300256]
AAB00 [2001300256]
—
—
—
1.0e+50
1.0e+50
—
3.2e+00
—
—
—
—
—
—
cases:2.38%
controls:0.00%
cases:1.60%
controls:0.00%
—
—
cases:1.61%
controls:0.07%
—
—
—
24
0
985
10081
16
0
984
10059
—
14
6
855
8679
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
Z50.8 [45556842]
3.6e-01
1.0e+00
—
—
—
1.7e+00
1.5e+00
cases:0.99%
controls:0.69%
cases:0.79%
controls:0.29%
—
—
—
—
—
—
cases:1.53%
controls:0.30%
cases:3.34%
controls:0.77%
10
70
999
10011
8
29
1001
10052
—
—
—
15
29
965
9794
29
67
840
8618
Uroflowmetry
44856007 [4261340]
44856007 [4261340]
4.3e-02
9.9e-01
-1.0e+50
—
—
1.2e+00
9.0e-01
cases:1.88%
controls:1.81%
cases:1.68%
controls:0.63%
cases:0.00%
controls:0.10%
—
—
—
—
cases:1.94%
controls:0.57%
cases:4.03%
controls:1.67%
19
182
990
9899
17
64
992
10017
0
10
1009
10071
—
—
19
56
961
9767
35
145
834
8540
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
4.5e-02
4.0e-01
1.2e+00
—
2.0e+00
6.5e-01
4.5e-01
cases:3.67%
controls:3.51%
cases:2.58%
controls:1.74%
cases:0.69%
controls:0.22%
—
—
cases:1.60%
controls:0.22%
cases:3.37%
controls:1.79%
cases:8.29%
controls:5.42%
37
354
972
9727
26
175
983
9906
7
22
1002
10059
—
16
22
984
10037
33
176
947
9647
72
471
797
8214
Implementation of occupational therapy rehabilitation plan
SPAT1226 [2001700327]
SPAT1226 [2001700327]
-1.0e+50
—
—
—
—
3.1e+00
1.5e+00
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.05%
cases:0.92%
controls:0.21%
0
7
1009
10074
—
—
—
—
11
5
969
9818
8
18
861
8667
General Practice
1 [38004446]
1 [38004446]
2.2e-01
4.3e-01
9.4e-01
—
2.0e+00
6.0e-01
5.0e-01
cases:12.78%
controls:10.55%
cases:6.24%
controls:4.14%
cases:1.39%
controls:0.55%
—
—
cases:3.40%
controls:0.49%
cases:7.24%
controls:4.12%
cases:19.10%
controls:12.53%
129
1064
880
9017
63
417
946
9664
14
55
995
10026
—
34
49
966
10010
71
405
909
9418
166
1088
703
7597
Examination of eyes and vision
Z01.0 [45566391]
Z01.0 [45566391]
5.6e-02
8.7e-01
1.5e+00
—
—
1.6e+00
6.3e-01
cases:2.38%
controls:2.25%
cases:2.18%
controls:0.92%
cases:0.69%
controls:0.15%
—
—
—
—
cases:4.08%
controls:0.89%
cases:5.87%
controls:3.20%
24
227
985
9854
22
93
987
9988
7
15
1002
10066
—
—
40
87
940
9736
51
278
818
8407
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
-9.5e-02
-4.7e-02
1.4e+00
—
1.4e+00
1.1e+00
5.6e-01
cases:4.46%
controls:4.88%
cases:1.49%
controls:1.56%
cases:0.79%
controls:0.20%
—
—
cases:1.00%
controls:0.25%
cases:3.67%
controls:1.26%
cases:7.71%
controls:4.56%
45
492
964
9589
15
157
994
9924
8
20
1001
10061
—
10
25
990
10034
36
124
944
9699
67
396
802
8289
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
1.1e-01
1.2e+00
—
—
1.8e+00
9.1e-01
4.8e-01
cases:1.59%
controls:1.42%
cases:2.38%
controls:0.71%
—
—
—
—
cases:0.80%
controls:0.13%
cases:1.53%
controls:0.62%
cases:2.65%
controls:1.65%
16
143
993
9938
24
72
985
10009
—
—
8
13
992
10046
15
61
965
9762
23
143
846
8542
Benign paroxysmal vertigo
H81.1 [45572061]
H81.1 [45572061]
3.7e-01
1.4e+00
—
—
—
1.6e+00
8.2e-01
cases:1.19%
controls:0.82%
cases:0.99%
controls:0.25%
—
—
—
—
—
—
cases:1.22%
controls:0.24%
cases:2.42%
controls:1.08%
12
83
997
9998
10
25
999
10056
—
—
—
12
24
968
9799
21
94
848
8591
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
-1.4e-01
1.0e-01
6.6e-01
3.0e+00
6.9e-01
2.9e-02
1.5e-01
cases:3.96%
controls:4.51%
cases:3.17%
controls:2.88%
cases:1.09%
controls:0.57%
cases:0.99%
controls:0.05%
cases:1.10%
controls:0.56%
cases:3.16%
controls:3.07%
cases:7.36%
controls:6.39%
40
455
969
9626
32
290
977
9791
11
57
998
10024
10
5
999
10076
11
56
989
10003
31
302
949
9521
64
555
805
8130
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
-8.3e-02
3.5e-01
1.0e+00
—
1.4e+00
5.1e-01
1.8e-01
cases:6.74%
controls:7.28%
cases:5.85%
controls:4.19%
cases:1.88%
controls:0.69%
—
—
cases:2.70%
controls:0.68%
cases:7.14%
controls:4.43%
cases:13.12%
controls:11.20%
68
734
941
9347
59
422
950
9659
19
70
990
10011
—
27
68
973
9991
70
435
910
9388
114
973
755
7712
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
1.5e-02
4.4e-01
1.2e+00
—
8.8e-01
3.3e-01
3.2e-01
cases:14.07%
controls:13.89%
cases:10.90%
controls:7.31%
cases:2.78%
controls:0.82%
—
—
cases:2.30%
controls:0.96%
cases:9.69%
controls:7.15%
cases:26.35%
controls:20.68%
142
1400
867
8681
110
737
899
9344
28
83
981
9998
—
23
97
977
9962
95
702
885
9121
229
1796
640
6889
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
2704-5 [3028626]
2.4e-01
9.9e-01
—
—
—
1.7e+00
1.1e+00
cases:0.59%
controls:0.47%
cases:0.69%
controls:0.26%
—
—
—
—
—
—
cases:1.02%
controls:0.18%
cases:1.61%
controls:0.52%
6
47
1003
10034
7
26
1002
10055
—
—
—
10
18
970
9805
14
45
855
8640
Immunohistochemistry procedure
117617002 [4035726]
117617002 [4035726]
4.8e-01
1.3e+00
—
—
—
1.6e+00
6.2e-01
cases:1.88%
controls:1.17%
cases:1.59%
controls:0.45%
—
—
—
—
—
—
cases:1.53%
controls:0.32%
cases:1.61%
controls:0.88%
19
118
990
9963
16
45
993
10036
—
—
—
15
31
965
9792
14
76
855
8609
Catheterisation of bladder
TKC20 [2001306020]
TKC20 [2001306020]
1.4e-01
9.6e-01
—
—
—
1.7e+00
1.2e+00
cases:0.59%
controls:0.52%
cases:0.59%
controls:0.23%
—
—
—
—
—
—
cases:1.12%
controls:0.21%
cases:1.50%
controls:0.46%
6
52
1003
10029
6
23
1003
10058
—
—
—
11
21
969
9802
13
40
856
8645
High dependency care
WX882 [2001310847]
WX882 [2001310847]
1.3e+00
—
—
—
—
2.8e+00
1.7e+00
cases:0.89%
controls:0.25%
—
—
—
—
—
—
—
—
cases:1.53%
controls:0.09%
cases:0.81%
controls:0.15%
9
25
1000
10056
—
—
—
—
15
9
965
9814
7
13
862
8672
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
2.9e-01
8.5e-01
—
1.0e+50
—
1.7e+00
1.1e+00
cases:4.36%
controls:3.28%
cases:1.59%
controls:0.68%
—
—
cases:1.19%
controls:0.00%
—
—
cases:3.27%
controls:0.63%
cases:4.60%
controls:1.51%
44
331
965
9750
16
69
993
10012
—
12
0
997
10081
—
32
62
948
9761
40
131
829
8554
Migraine with aura [classical migraine]
G43.1 [45562086]
G43.1 [45562086]
5.0e-01
1.5e+00
—
1.0e+50
2.1e+00
1.3e+00
5.2e-01
cases:1.29%
controls:0.78%
cases:1.19%
controls:0.27%
—
—
cases:0.69%
controls:0.00%
cases:0.50%
controls:0.06%
cases:1.63%
controls:0.45%
cases:1.73%
controls:1.04%
13
79
996
10002
12
27
997
10054
—
7
0
1002
10081
5
6
995
10053
16
44
964
9779
15
90
854
8595
MRI examination of vessels in the head with high intensity magnet
PA2BG [2001308681]
PA2BG [2001308681]
—
—
—
1.0e+50
—
—
2.8e+00
—
—
—
—
—
—
cases:0.59%
controls:0.00%
—
—
—
—
cases:1.50%
controls:0.09%
—
—
—
6
0
1003
10081
—
—
13
8
856
8677
Aortic aneurysm of unspecified site, without mention of rupture
I71.9 [45581813]
I71.9 [45581813]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.06%
—
—
—
—
—
—
8
5
861
8680
Neuropsychological evaluation of need and possibilities to rehabilitation
R1230 [2001310176]
R1230 [2001310176]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.06%
—
—
—
—
—
—
8
5
861
8680
lamotrigine; oral
N03AX09 [21604431]
N03AX09 [21604431]
4.8e-01
8.6e-01
—
—
—
1.3e+00
1.4e+00
cases:0.99%
controls:0.62%
cases:0.79%
controls:0.34%
—
—
—
—
—
—
cases:1.53%
controls:0.42%
cases:3.11%
controls:0.77%
10
62
999
10019
8
34
1001
10047
—
—
—
15
41
965
9782
27
67
842
8618
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
34548-8 [3045783]
-9.6e-02
1.9e-01
1.9e+00
—
1.6e+00
7.8e-01
2.5e-01
cases:3.07%
controls:3.37%
cases:1.98%
controls:1.65%
cases:0.79%
controls:0.12%
—
—
cases:0.70%
controls:0.14%
cases:3.06%
controls:1.43%
cases:4.14%
controls:3.27%
31
340
978
9741
20
166
989
9915
8
12
1001
10069
—
7
14
993
10045
30
140
950
9683
36
284
833
8401
Other investigative procedure of eye
XCW99 [2001301491]
XCW99 [2001301491]
4.6e-01
1.0e+00
1.7e+00
—
—
1.6e+00
3.9e-01
cases:2.08%
controls:1.32%
cases:1.49%
controls:0.53%
cases:0.50%
controls:0.09%
—
—
—
—
cases:2.14%
controls:0.44%
cases:2.30%
controls:1.57%
21
133
988
9948
15
53
994
10028
5
9
1004
10072
—
—
21
43
959
9780
20
136
849
8549
Third [oculomotor] nerve palsy
H49.0 [45586494]
H49.0 [45586494]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.06%
—
—
—
—
—
—
7
5
862
8680
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
4.7e-01
1.7e+00
—
—
—
7.0e-01
8.8e-01
cases:1.88%
controls:1.19%
cases:2.18%
controls:0.39%
—
—
—
—
—
—
cases:1.02%
controls:0.51%
cases:4.72%
controls:2.00%
19
120
990
9961
22
39
987
10042
—
—
—
10
50
970
9773
41
174
828
8511
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
4.4e-01
8.4e-01
1.3e+00
—
—
8.8e-01
9.1e-01
cases:3.96%
controls:2.58%
cases:2.38%
controls:1.04%
cases:0.79%
controls:0.21%
—
—
—
—
cases:2.45%
controls:1.03%
cases:6.44%
controls:2.71%
40
260
969
9821
24
105
985
9976
8
21
1001
10060
—
—
24
101
956
9722
56
235
813
8450
Intracerebral haemorrhage, unspecified
I61.9 [45576882]
I61.9 [45576882]
—
—
1.0e+50
1.0e+50
1.0e+50
—
2.6e+00
—
—
—
—
cases:1.29%
controls:0.00%
cases:1.49%
controls:0.00%
cases:1.10%
controls:0.00%
—
—
cases:0.92%
controls:0.07%
—
—
13
0
996
10081
15
0
994
10081
11
0
989
10059
—
8
6
861
8679
Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
3193-0 [3005757]
3193-0 [3005757]
—
2.6e+00
—
—
—
—
—
—
—
cases:0.79%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
8
6
1001
10075
—
—
—
—
—
Bilateral
ZXA10 [2001311348]
ZXA10 [2001311348]
3.2e-01
7.2e-01
—
—
-1.0e+50
1.6e+00
9.3e-01
cases:2.78%
controls:2.02%
cases:1.09%
controls:0.54%
—
—
—
—
cases:0.00%
controls:0.05%
cases:2.04%
controls:0.41%
cases:4.14%
controls:1.67%
28
204
981
9877
11
54
998
10027
—
—
0
5
1000
10054
20
40
960
9783
36
145
833
8540
CT angiography of head and neck vasculature
PA7AD [2001300233]
PA7AD [2001300233]
1.3e+00
2.6e+00
—
1.0e+50
—
—
—
cases:0.50%
controls:0.13%
cases:0.89%
controls:0.07%
—
—
cases:0.69%
controls:0.00%
—
—
—
—
—
—
5
13
1004
10068
9
7
1000
10074
—
7
0
1002
10081
—
—
—
Sequelae of cerebral infarction
I69.3 [45533476]
I69.3 [45533476]
-9.0e-04
3.0e-01
—
1.0e+50
1.7e+00
1.3e+00
1.3e+00
cases:0.69%
controls:0.69%
cases:0.50%
controls:0.37%
—
—
cases:0.79%
controls:0.00%
cases:0.60%
controls:0.11%
cases:1.84%
controls:0.51%
cases:4.26%
controls:1.26%
7
70
1002
10011
5
37
1004
10044
—
8
0
1001
10081
6
11
994
10048
18
50
962
9773
37
109
832
8576
More than five and less than seven hours
ZXE30 [2001311411]
ZXE30 [2001311411]
2.1e-01
1.4e+00
—
—
—
2.5e+00
1.3e+00
cases:0.69%
controls:0.57%
cases:0.50%
controls:0.12%
—
—
—
—
—
—
cases:1.53%
controls:0.12%
cases:0.58%
controls:0.16%
7
57
1002
10024
5
12
1004
10069
—
—
—
15
12
965
9811
5
14
864
8671
Assessment of need for medical rehabilitation
SPAT1215 [2001700316]
SPAT1215 [2001700316]
-1.0e+50
—
—
—
—
2.5e+00
1.4e+00
cases:0.00%
controls:0.40%
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.08%
cases:1.04%
controls:0.25%
0
40
1009
10041
—
—
—
—
10
8
970
9815
9
22
860
8663
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
2.5e-01
7.9e-01
1.4e+00
—
1.7e+00
-2.9e-01
3.9e-01
cases:2.58%
controls:2.01%
cases:2.68%
controls:1.23%
cases:0.59%
controls:0.15%
—
—
cases:0.90%
controls:0.16%
cases:1.12%
controls:1.50%
cases:6.33%
controls:4.38%
26
203
983
9878
27
124
982
9957
6
15
1003
10066
—
9
16
991
10043
11
147
969
9676
55
380
814
8305
Extensive MRI examination of brain with 3 Tesla magnet
AA1CM [2001300117]
AA1CM [2001300117]
2.0e+00
—
1.0e+50
1.0e+50
—
—
2.5e+00
cases:0.50%
controls:0.07%
—
—
cases:0.50%
controls:0.00%
cases:0.50%
controls:0.00%
—
—
—
—
cases:1.38%
controls:0.12%
5
7
1004
10074
—
5
0
1004
10081
5
0
1004
10081
—
—
12
10
857
8675
Other skin changes
R23 [45568122]
R23 [45568122]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.06%
—
—
—
—
—
—
6
5
863
8680
Ligature of intracranial aneurysm
AAC00 [2001300262]
AAC00 [2001300262]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.06%
—
—
—
—
—
—
6
5
863
8680
Other epilepsy
G40.89 [2000502156]
G40.89 [2000502156]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.06%
—
—
—
—
—
—
6
5
863
8680
Grand mal seizures, unspecified (with or without petit mal)
G40.6 [45586284]
G40.6 [45586284]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.06%
—
—
—
—
—
—
6
5
863
8680
Subarachnoid haemorrhage, unspecified
I60.9 [45591472]
I60.9 [45591472]
2.5e+00
—
1.0e+50
—
—
—
2.1e+00
cases:0.59%
controls:0.05%
—
—
cases:0.59%
controls:0.00%
—
—
—
—
—
—
cases:0.58%
controls:0.07%
6
5
1003
10076
—
6
0
1003
10081
—
—
—
5
6
864
8679
IgG [Mass/volume] in Cerebral spinal fluid
2464-6 [3007368]
2464-6 [3007368]
—
2.5e+00
—
—
—
—
—
—
—
cases:0.59%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
6
5
1003
10076
—
—
—
—
—
Extensive CT of head and brain
AA1BD [2001300110]
AA1BD [2001300110]
1.0e+00
2.5e+00
—
—
—
—
—
cases:0.50%
controls:0.18%
cases:0.59%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
5
18
1004
10063
6
5
1003
10076
—
—
—
—
—
Albumin [Mass/volume] in Cerebral spinal fluid
1746-7 [3024474]
1746-7 [3024474]
—
2.5e+00
—
—
—
—
—
—
—
cases:0.59%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
6
5
1003
10076
—
—
—
—
—
Hemiplegia, unspecified
G81.9 [45562106]
G81.9 [45562106]
-1.0e+50
—
—
—
—
—
2.5e+00
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.07%
0
5
1009
10076
—
—
—
—
—
7
6
862
8679
Other amnesia
R41.3 [45539342]
R41.3 [45539342]
—
2.5e+00
—
—
—
—
—
—
—
cases:0.69%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
7
6
1002
10075
—
—
—
—
—
Psychiatry
26 [38004469]
26 [38004469]
3.4e-01
5.1e-01
7.1e-01
—
7.8e-01
8.8e-01
8.0e-01
cases:7.43%
controls:5.40%
cases:4.76%
controls:2.92%
cases:2.28%
controls:1.13%
—
—
cases:2.80%
controls:1.30%
cases:6.63%
controls:2.87%
cases:11.74%
controls:5.63%
75
544
934
9537
48
294
961
9787
23
114
986
9967
—
28
131
972
9928
65
282
915
9541
102
489
767
8196
Use of surgical navigator
ZXC95 [2001311381]
ZXC95 [2001311381]
—
—
—
—
1.0e+50
—
2.4e+00
—
—
—
—
—
—
—
—
cases:0.60%
controls:0.00%
—
—
cases:0.92%
controls:0.08%
—
—
—
—
6
0
994
10059
—
8
7
861
8678
Extensive CT of neck arteries
PA6BD [2001308697]
PA6BD [2001308697]
6.7e-01
2.4e+00
—
1.0e+50
—
—
8.8e-01
cases:0.69%
controls:0.36%
cases:0.79%
controls:0.07%
—
—
cases:0.79%
controls:0.00%
—
—
—
—
cases:0.69%
controls:0.29%
7
36
1002
10045
8
7
1001
10074
—
8
0
1001
10081
—
—
6
25
863
8660
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
7.1e-02
6.6e-01
1.5e+00
—
2.4e+00
8.4e-01
2.3e-01
cases:2.18%
controls:2.03%
cases:1.49%
controls:0.77%
cases:0.50%
controls:0.11%
—
—
cases:0.90%
controls:0.08%
cases:1.94%
controls:0.84%
cases:3.57%
controls:2.87%
22
205
987
9876
15
78
994
10003
5
11
1004
10070
—
9
8
991
10051
19
83
961
9740
31
249
838
8436
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
87975-9 [36305247]
5.1e-01
—
—
—
—
2.4e+00
1.1e+00
cases:0.50%
controls:0.30%
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.08%
cases:1.27%
controls:0.43%
5
30
1004
10051
—
—
—
—
9
8
971
9815
11
37
858
8648
Cerebrovascular disease
K91 [2002000618]
K91 [2002000618]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.09%
—
—
—
—
—
—
9
8
860
8677
Other visual field testing
CS494 [2001301478]
CS494 [2001301478]
-1.0e+50
—
—
—
—
2.4e+00
1.1e+00
cases:0.00%
controls:0.27%
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.09%
cases:0.69%
controls:0.23%
0
27
1009
10054
—
—
—
—
10
9
970
9814
6
20
863
8665
Other spondylosis with radiculopathy
M47.2 [45591850]
M47.2 [45591850]
-1.3e-02
8.0e-01
—
—
—
1.4e+00
1.0e+00
cases:0.79%
controls:0.80%
cases:0.59%
controls:0.27%
—
—
—
—
—
—
cases:1.12%
controls:0.27%
cases:1.73%
controls:0.64%
8
81
1001
10000
6
27
1003
10054
—
—
—
11
27
969
9796
15
56
854
8629
Observation for suspected nervous system disorder
Z03.3 [45609903]
Z03.3 [45609903]
7.4e-01
2.4e+00
—
—
—
1.3e+00
7.2e-01
cases:0.99%
controls:0.48%
cases:1.19%
controls:0.11%
—
—
—
—
—
—
cases:0.82%
controls:0.21%
cases:1.27%
controls:0.62%
10
48
999
10033
12
11
997
10070
—
—
—
8
21
972
9802
11
54
858
8631
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
3.9e-03
4.3e-01
1.1e+00
—
8.6e-01
3.2e-01
2.2e-01
cases:16.85%
controls:16.79%
cases:12.88%
controls:8.77%
cases:3.47%
controls:1.19%
—
—
cases:2.70%
controls:1.16%
cases:11.73%
controls:8.82%
cases:27.16%
controls:23.11%
170
1693
839
8388
130
884
879
9197
35
120
974
9961
—
27
117
973
9942
115
866
865
8957
236
2007
633
6678
Physiologic investigation of micturition
XKD06 [2001306098]
XKD06 [2001306098]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.13%
—
—
—
—
—
—
11
11
858
8674
Bacteria identified in Cerebral spinal fluid by Culture
606-4 [3016914]
606-4 [3016914]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.09%
—
—
—
—
—
—
—
9
9
971
9814
—
Appearance of Cerebral spinal fluid
10333-3 [3023410]
10333-3 [3023410]
1.1e+00
—
—
—
—
2.3e+00
—
cases:0.50%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.07%
—
—
5
17
1004
10064
—
—
—
—
7
7
973
9816
—
Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
3181-5 [3009041]
3181-5 [3009041]
—
1.4e+00
—
—
—
2.3e+00
7.4e-01
—
—
cases:0.59%
controls:0.15%
—
—
—
—
—
—
cases:0.71%
controls:0.07%
cases:0.58%
controls:0.28%
—
6
15
1003
10066
—
—
—
7
7
973
9816
5
24
864
8661
Intensive care
WX872 [2001310844]
WX872 [2001310844]
-4.0e-02
1.3e+00
—
1.0e+50
—
2.3e+00
2.5e-01
cases:0.50%
controls:0.52%
cases:0.59%
controls:0.17%
—
—
cases:0.59%
controls:0.00%
—
—
cases:0.61%
controls:0.06%
cases:0.58%
controls:0.45%
5
52
1004
10029
6
17
1003
10064
—
6
0
1003
10081
—
6
6
974
9817
5
39
864
8646
Supporting bandage or orthosis of lower limb
TNX92 [2001308571]
TNX92 [2001308571]
—
-1.0e+50
—
—
—
—
2.3e+00
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.09%
—
0
6
1009
10075
—
—
—
—
8
8
861
8677
Neuro-ophthalmology Physician
207WX0109X [903241]
207WX0109X [903241]
—
—
—
—
—
1.0e+50
2.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.00%
cases:0.81%
controls:0.08%
—
—
—
—
—
8
0
972
9823
7
7
862
8678
Short MRI examination of brain with median intensity magnet
AA1AG [2001300107]
AA1AG [2001300107]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.08%
—
—
—
—
—
—
7
7
862
8678
CT of neck arteries
PA6AD [2001308692]
PA6AD [2001308692]
1.1e+00
2.3e+00
—
1.0e+50
—
—
3.3e-01
cases:0.50%
controls:0.16%
cases:0.79%
controls:0.08%
—
—
cases:0.59%
controls:0.00%
—
—
—
—
cases:0.69%
controls:0.50%
5
16
1004
10065
8
8
1001
10073
—
6
0
1003
10081
—
—
6
43
863
8642
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
1.1e-01
3.0e-01
9.4e-01
—
8.8e-01
1.2e-01
4.4e-01
cases:6.94%
controls:6.29%
cases:5.75%
controls:4.33%
cases:1.98%
controls:0.78%
—
—
cases:2.10%
controls:0.88%
cases:5.31%
controls:4.74%
cases:13.12%
controls:8.84%
70
634
939
9447
58
437
951
9644
20
79
989
10002
—
21
89
979
9970
52
466
928
9357
114
768
755
7917
Ultrasound measurement of residual urine
KC1EE [2001305918]
KC1EE [2001305918]
-7.7e-03
6.4e-01
-1.0e+50
—
—
1.2e+00
1.1e+00
cases:1.49%
controls:1.50%
cases:1.09%
controls:0.58%
cases:0.00%
controls:0.07%
—
—
—
—
cases:1.84%
controls:0.57%
cases:4.26%
controls:1.51%
15
151
994
9930
11
58
998
10023
0
7
1009
10074
—
—
18
56
962
9767
37
131
832
8554
amitriptyline; oral, parenteral
N06AA09 [21604696]
N06AA09 [21604696]
3.2e-01
7.6e-01
8.7e-01
—
5.2e-01
8.0e-01
6.6e-01
cases:5.25%
controls:3.86%
cases:4.06%
controls:1.94%
cases:0.99%
controls:0.42%
—
—
cases:0.80%
controls:0.48%
cases:4.49%
controls:2.07%
cases:8.63%
controls:4.67%
53
389
956
9692
41
196
968
9885
10
42
999
10039
—
8
48
992
10011
44
203
936
9620
75
406
794
8279
Cerebral infarction due to thrombosis of cerebral arteries
I63.3 [45562366]
I63.3 [45562366]
—
2.2e+00
—
1.0e+50
—
—
1.2e+00
—
—
cases:0.99%
controls:0.11%
—
—
cases:0.59%
controls:0.00%
—
—
—
—
cases:1.15%
controls:0.35%
—
10
11
999
10070
—
6
0
1003
10081
—
—
10
30
859
8655
baclofen; oral, parenteral
M03BX01 [21604115]
M03BX01 [21604115]
1.5e+00
—
—
—
—
1.8e+00
2.2e+00
cases:0.59%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.61%
controls:0.10%
cases:2.07%
controls:0.23%
6
13
1003
10068
—
—
—
—
6
10
974
9813
18
20
851
8665
Neck artery ultrasound examination with Doppler method
PA6DE [2001308705]
PA6DE [2001308705]
2.9e-01
2.2e+00
—
—
—
—
—
cases:0.59%
controls:0.45%
cases:0.79%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
6
45
1003
10036
8
9
1001
10072
—
—
—
—
—
Acute tubulo-interstitial nephritis
N10 [45543856]
N10 [45543856]
6.0e-02
9.8e-01
-1.0e+50
—
2.2e+00
1.0e+00
7.2e-01
cases:1.19%
controls:1.12%
cases:0.89%
controls:0.34%
cases:0.00%
controls:0.05%
—
—
cases:0.70%
controls:0.08%
cases:1.02%
controls:0.37%
cases:2.76%
controls:1.36%
12
113
997
9968
9
34
1000
10047
0
5
1009
10076
—
7
8
993
10051
10
36
970
9787
24
118
845
8567
Other extensive ultrasound examination of artery
PG1DE [2001309713]
PG1DE [2001309713]
1.0e+00
—
—
—
—
2.2e+00
3.0e-01
cases:1.19%
controls:0.43%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.08%
cases:0.58%
controls:0.43%
12
43
997
10038
—
—
—
—
7
8
973
9815
5
37
864
8648
Malaise and fatigue
R53 [45553741]
R53 [45553741]
1.3e-01
5.2e-01
2.2e+00
—
—
4.6e-01
4.5e-01
cases:2.78%
controls:2.44%
cases:1.78%
controls:1.07%
cases:0.69%
controls:0.08%
—
—
—
—
cases:1.63%
controls:1.04%
cases:5.87%
controls:3.83%
28
246
981
9835
18
108
991
9973
7
8
1002
10073
—
—
16
102
964
9721
51
333
818
8352
Other depressive episodes
F32.8 [45571759]
F32.8 [45571759]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.08%
—
—
—
—
—
—
6
7
863
8678
Cerebral infarction due to embolism of cerebral arteries
I63.4 [45591475]
I63.4 [45591475]
—
2.2e+00
—
—
—
1.8e+00
—
—
—
cases:0.59%
controls:0.07%
—
—
—
—
—
—
cases:0.51%
controls:0.08%
—
—
—
6
7
1003
10074
—
—
—
5
8
975
9815
—
Monitoring vital functions without anesthesia
WX000 [2001310756]
WX000 [2001310756]
—
1.7e+00
—
—
—
2.1e+00
1.3e+00
—
—
cases:0.50%
controls:0.09%
—
—
—
—
—
—
cases:1.12%
controls:0.13%
cases:0.81%
controls:0.22%
—
5
9
1004
10072
—
—
—
11
13
969
9810
7
19
862
8666
General Surgery
2 [38004447]
2 [38004447]
9.9e-02
3.4e-01
1.1e+00
—
8.5e-01
5.5e-01
4.5e-01
cases:17.74%
controls:16.35%
cases:6.64%
controls:4.81%
cases:1.88%
controls:0.62%
—
—
cases:1.70%
controls:0.74%
cases:7.55%
controls:4.50%
cases:18.30%
controls:12.53%
179
1648
830
8433
67
485
942
9596
19
63
990
10018
—
17
74
983
9985
74
442
906
9381
159
1088
710
7597
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
5.0e-02
1.2e+00
—
1.0e+50
—
9.1e-01
3.4e-01
cases:2.68%
controls:2.55%
cases:2.58%
controls:0.80%
—
—
cases:0.69%
controls:0.00%
—
—
cases:2.55%
controls:1.04%
cases:4.72%
controls:3.41%
27
257
982
9824
26
81
983
10000
—
7
0
1002
10081
—
25
102
955
9721
41
296
828
8389
Speech therapy
R4130 [2001310235]
R4130 [2001310235]
—
-1.0e+50
-1.0e+50
—
—
2.1e+00
1.5e+00
—
—
cases:0.00%
controls:0.08%
cases:0.00%
controls:0.05%
—
—
—
—
cases:0.82%
controls:0.10%
cases:0.92%
controls:0.21%
—
0
8
1009
10073
0
5
1009
10076
—
—
8
10
972
9813
8
18
861
8667
Ankle and foot MRI examination with high intensity magnet
NH1BG [2001308242]
NH1BG [2001308242]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.12%
—
—
—
—
—
—
8
10
861
8675
Potassium [Moles/volume] in Arterial blood
32713-0 [3043409]
32713-0 [3043409]
—
—
—
—
—
2.1e+00
6.8e-01
—
—
—
—
—
—
—
—
—
—
cases:1.53%
controls:0.19%
cases:1.04%
controls:0.53%
—
—
—
—
—
15
19
965
9804
9
46
860
8639
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
44448-9 [3044355]
44448-9 [3044355]
—
—
—
—
—
2.1e+00
7.4e-01
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.09%
cases:0.58%
controls:0.28%
—
—
—
—
—
7
9
973
9814
5
24
864
8661
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
2.6e-01
4.2e-01
7.6e-01
—
1.1e+00
5.1e-01
4.3e-01
cases:17.15%
controls:13.73%
cases:7.83%
controls:5.31%
cases:1.98%
controls:0.93%
—
—
cases:2.60%
controls:0.88%
cases:8.27%
controls:5.15%
cases:21.40%
controls:15.04%
173
1384
836
8697
79
535
930
9546
20
94
989
9987
—
26
89
974
9970
81
506
899
9317
186
1306
683
7379
Spine and spinal cord extensive MRI examination with high intensity magnet
NA7CG [2001307081]
NA7CG [2001307081]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.09%
—
—
—
—
—
—
6
8
863
8677
X-ray of knees
NG1DA [2001308067]
NG1DA [2001308067]
-1.0e+50
—
—
—
—
—
2.0e+00
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.09%
0
11
1009
10070
—
—
—
—
—
6
8
863
8677
Depressive episode, unspecified
F32.9 [45571760]
F32.9 [45571760]
6.3e-01
1.0e+00
—
—
—
7.4e-01
9.5e-01
cases:2.58%
controls:1.39%
cases:1.39%
controls:0.50%
—
—
—
—
—
—
cases:1.02%
controls:0.49%
cases:3.91%
controls:1.55%
26
140
983
9941
14
50
995
10031
—
—
—
10
48
970
9775
34
135
835
8550
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
-4.1e-02
3.0e-01
7.2e-01
—
1.0e+00
1.2e+00
7.1e-01
cases:6.44%
controls:6.70%
cases:3.27%
controls:2.44%
cases:0.89%
controls:0.44%
—
—
cases:1.20%
controls:0.44%
cases:7.45%
controls:2.26%
cases:12.54%
controls:6.60%
65
675
944
9406
33
246
976
9835
9
44
1000
10037
—
12
44
988
10015
73
222
907
9601
109
573
760
8112
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
—
1.1e+00
—
—
—
1.9e+00
6.8e-01
—
—
cases:0.59%
controls:0.21%
—
—
—
—
—
—
cases:2.45%
controls:0.36%
cases:2.07%
controls:1.06%
—
6
21
1003
10060
—
—
—
24
35
956
9788
18
92
851
8593
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
2.0e-01
1.9e-01
4.4e-01
—
9.8e-01
5.8e-01
3.9e-01
cases:36.67%
controls:32.26%
cases:20.71%
controls:17.70%
cases:4.46%
controls:2.91%
—
—
cases:6.80%
controls:2.66%
cases:27.55%
controls:17.56%
cases:48.45%
controls:38.94%
370
3252
639
6829
209
1784
800
8297
45
293
964
9788
—
68
268
932
9791
270
1725
710
8098
421
3382
448
5303
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
1.5e-01
6.7e-01
1.1e+00
—
1.9e+00
4.9e-01
4.0e-01
cases:2.58%
controls:2.22%
cases:2.78%
controls:1.44%
cases:0.69%
controls:0.23%
—
—
cases:1.70%
controls:0.25%
cases:2.04%
controls:1.26%
cases:4.49%
controls:3.06%
26
224
983
9857
28
145
981
9936
7
23
1002
10058
—
17
25
983
10034
20
124
960
9699
39
266
830
8419
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
2518-9 [3018405]
—
—
—
—
—
1.9e+00
5.3e-01
—
—
—
—
—
—
—
—
—
—
cases:1.53%
controls:0.22%
cases:1.04%
controls:0.61%
—
—
—
—
—
15
22
965
9801
9
53
860
8632
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
47598-8 [3048816]
1.6e-01
6.6e-01
—
—
1.9e+00
8.1e-01
5.6e-01
cases:1.29%
controls:1.10%
cases:1.39%
controls:0.72%
—
—
—
—
cases:0.80%
controls:0.12%
cases:1.22%
controls:0.55%
cases:2.76%
controls:1.59%
13
111
996
9970
14
73
995
10008
—
—
8
12
992
10047
12
54
968
9769
24
138
845
8547
Gas panel - Central venous blood
97535-9 [1616796]
97535-9 [1616796]
—
—
—
—
—
1.9e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.12%
cases:0.81%
controls:0.25%
—
—
—
—
—
8
12
972
9811
7
22
862
8663
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
3016-3 [3009201]
2.3e-02
3.6e-01
8.6e-01
—
6.7e-01
9.5e-02
2.0e-01
cases:24.08%
controls:23.67%
cases:19.62%
controls:14.51%
cases:4.66%
controls:2.02%
—
—
cases:3.20%
controls:1.67%
cases:16.94%
controls:15.65%
cases:42.00%
controls:37.16%
243
2386
766
7695
198
1463
811
8618
47
204
962
9877
—
32
168
968
9891
166
1537
814
8286
365
3227
504
5458
dexamethasone; oral, parenteral
H02AB02 [21602730]
H02AB02 [21602730]
2.7e-01
4.5e-01
1.9e+00
—
1.4e+00
6.7e-01
2.9e-01
cases:2.78%
controls:2.13%
cases:1.49%
controls:0.95%
cases:0.89%
controls:0.14%
—
—
cases:0.60%
controls:0.15%
cases:1.84%
controls:0.95%
cases:4.03%
controls:3.04%
28
215
981
9866
15
96
994
9985
9
14
1000
10067
—
6
15
994
10044
18
93
962
9730
35
264
834
8421
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
3.1e-01
6.5e-01
9.2e-01
—
6.3e-01
6.0e-01
6.2e-01
cases:10.21%
controls:7.70%
cases:4.66%
controls:2.49%
cases:1.39%
controls:0.56%
—
—
cases:1.00%
controls:0.54%
cases:4.90%
controls:2.76%
cases:13.12%
controls:7.51%
103
776
906
9305
47
251
962
9830
14
56
995
10025
—
10
54
990
10005
48
271
932
9552
114
652
755
8033
Hemoglobin [Mass/volume] in Capillary blood
30352-9 [3006184]
30352-9 [3006184]
—
—
—
—
—
1.9e+00
5.7e-01
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.11%
cases:0.69%
controls:0.39%
—
—
—
—
—
7
11
973
9812
6
34
863
8651
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
F32.3 [45600739]
—
-1.0e+50
—
—
—
—
1.9e+00
—
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.13%
—
0
7
1009
10074
—
—
—
—
7
11
862
8674
Optical coherence tomography (OCT) of ocular fundus
CK2X4 [2001301456]
CK2X4 [2001301456]
-2.3e-01
5.3e-01
—
—
—
1.1e+00
7.4e-01
cases:0.69%
controls:0.87%
cases:0.99%
controls:0.59%
—
—
—
—
—
—
cases:1.53%
controls:0.51%
cases:2.99%
controls:1.45%
7
88
1002
9993
10
59
999
10022
—
—
—
15
50
965
9773
26
126
843
8559
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
M51.1 [45562747]
-3.4e-02
7.3e-01
—
—
—
1.1e+00
7.5e-01
cases:1.78%
controls:1.85%
cases:1.39%
controls:0.67%
—
—
—
—
—
—
cases:1.63%
controls:0.55%
cases:4.14%
controls:2.00%
18
186
991
9895
14
68
995
10013
—
—
—
16
54
964
9769
36
174
833
8511
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
48065-7 [3051714]
2.2e-01
5.7e-01
1.2e+00
—
1.8e+00
6.4e-01
4.2e-01
cases:4.16%
controls:3.35%
cases:2.58%
controls:1.48%
cases:0.59%
controls:0.18%
—
—
cases:1.00%
controls:0.16%
cases:2.45%
controls:1.30%
cases:7.71%
controls:5.20%
42
338
967
9743
26
149
983
9932
6
18
1003
10063
—
10
16
990
10043
24
128
956
9695
67
452
802
8233
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
ZXE13 [2001311404]
7.4e-01
—
-1.0e+50
—
—
—
1.8e+00
cases:0.89%
controls:0.43%
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
cases:0.92%
controls:0.15%
9
43
1000
10038
—
0
5
1009
10076
—
—
—
8
13
861
8672
CT angiography of brain
PA2AD [2001300223]
PA2AD [2001300223]
—
—
—
1.0e+50
—
—
1.8e+00
—
—
—
—
—
—
cases:1.29%
controls:0.00%
—
—
—
—
cases:0.92%
controls:0.15%
—
—
—
13
0
996
10081
—
—
8
13
861
8672
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
—
—
—
—
—
1.8e+00
4.1e-01
—
—
—
—
—
—
—
—
—
—
cases:2.35%
controls:0.39%
cases:1.84%
controls:1.23%
—
—
—
—
—
23
38
957
9785
16
107
853
8578
Contact with and exposure to infections with a predominantly sexual mode of transmission
Z20.2 [45609914]
Z20.2 [45609914]
1.8e+00
—
—
—
—
—
—
cases:0.79%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
8
13
1001
10068
—
—
—
—
—
—
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
F43.22 [2000502003]
3.0e-01
—
-1.0e+50
—
—
1.8e+00
7.4e-01
cases:0.50%
controls:0.37%
—
—
cases:0.00%
controls:0.05%
—
—
—
—
cases:0.92%
controls:0.15%
cases:1.15%
controls:0.55%
5
37
1004
10044
—
0
5
1009
10076
—
—
9
15
971
9808
10
48
859
8637
Other specified local infections of skin and subcutaneous tissue
L08.8 [45601211]
L08.8 [45601211]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.17%
—
—
—
—
—
—
9
15
860
8670
Standard cardiac ultrasound examination
FM1AE [2001303278]
FM1AE [2001303278]
3.8e-01
2.4e-01
—
—
—
1.0e+00
7.8e-01
cases:3.47%
controls:2.39%
cases:1.39%
controls:1.09%
—
—
—
—
—
—
cases:2.24%
controls:0.82%
cases:5.18%
controls:2.45%
35
241
974
9840
14
110
995
9971
—
—
—
22
81
958
9742
45
213
824
8472
Blasts/Leukocytes in Blood
26446-5 [3025159]
26446-5 [3025159]
-9.7e-02
5.7e-01
—
—
1.8e+00
6.2e-01
2.5e-01
cases:0.79%
controls:0.87%
cases:1.29%
controls:0.73%
—
—
—
—
cases:0.70%
controls:0.12%
cases:1.63%
controls:0.89%
cases:2.88%
controls:2.26%
8
88
1001
9993
13
74
996
10007
—
—
7
12
993
10047
16
87
964
9736
25
196
844
8489
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
46424-8 [3052851]
2.4e-01
—
—
—
—
1.8e+00
1.1e+00
cases:0.79%
controls:0.62%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.12%
cases:0.81%
controls:0.26%
8
63
1001
10018
—
—
—
—
7
12
973
9811
7
23
862
8662
Benign tumor of the meninges on the outer surface of the cerebrum
D32.00 [2000501307]
D32.00 [2000501307]
-1.0e+50
1.9e+00
—
—
—
2.1e+00
1.8e+00
cases:0.00%
controls:0.09%
cases:0.59%
controls:0.09%
—
—
—
—
—
—
cases:0.51%
controls:0.06%
cases:0.81%
controls:0.14%
0
9
1009
10072
6
9
1003
10072
—
—
—
5
6
975
9817
7
12
862
8673
Pulmonary embolism with mention of acute cor pulmonale
I26.0 [45567169]
I26.0 [45567169]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.14%
—
—
—
—
—
—
7
12
862
8673
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
17792-3 [3023939]
17792-3 [3023939]
—
1.8e+00
—
—
—
1.4e+00
8.0e-01
—
—
cases:0.69%
controls:0.12%
—
—
—
—
—
—
cases:0.51%
controls:0.12%
cases:0.92%
controls:0.41%
—
7
12
1002
10069
—
—
—
5
12
975
9811
8
36
861
8649
alendronic acid and colecalciferol; oral
M05BB03 [21604160]
M05BB03 [21604160]
—
1.8e+00
—
—
-1.0e+50
—
1.4e+00
—
—
cases:0.69%
controls:0.12%
—
—
—
—
cases:0.00%
controls:0.05%
—
—
cases:0.58%
controls:0.14%
—
7
12
1002
10069
—
—
0
5
1000
10054
—
5
12
864
8673
tolterodine; oral
G04BD07 [21602640]
G04BD07 [21602640]
—
—
-1.0e+50
—
—
—
1.8e+00
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
cases:1.38%
controls:0.24%
—
—
0
6
1009
10075
—
—
—
12
21
857
8664
Electrophysiological examination of eye
XCD10 [2001300413]
XCD10 [2001300413]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.16%
—
—
—
—
—
—
8
14
861
8671
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
-1.2e-01
3.9e-01
—
—
1.7e+00
5.3e-01
2.7e-01
cases:3.87%
controls:4.34%
cases:3.37%
controls:2.30%
—
—
—
—
cases:1.60%
controls:0.29%
cases:4.29%
controls:2.57%
cases:9.55%
controls:7.44%
39
438
970
9643
34
232
975
9849
—
—
16
29
984
10030
42
252
938
9571
83
646
786
8039
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
1.8e-02
2.7e-01
9.8e-01
—
7.3e-01
3.1e-01
2.9e-01
cases:10.51%
controls:10.34%
cases:8.82%
controls:6.87%
cases:3.07%
controls:1.17%
—
—
cases:2.70%
controls:1.32%
cases:9.59%
controls:7.21%
cases:19.68%
controls:15.51%
106
1042
903
9039
89
693
920
9388
31
118
978
9963
—
27
133
973
9926
94
708
886
9115
171
1347
698
7338
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
1.6e-01
3.3e-01
8.9e-01
2.0e+00
8.1e-01
3.5e-01
3.0e-01
cases:10.80%
controls:9.34%
cases:7.43%
controls:5.46%
cases:2.38%
controls:0.99%
cases:0.50%
controls:0.07%
cases:2.50%
controls:1.12%
cases:7.76%
controls:5.59%
cases:17.26%
controls:13.33%
109
942
900
9139
75
550
934
9531
24
100
985
9981
5
7
1004
10074
25
113
975
9946
76
549
904
9274
150
1158
719
7527
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
4.3e-02
3.2e-01
9.4e-01
—
7.5e-01
3.5e-01
3.1e-01
cases:9.71%
controls:9.34%
cases:8.42%
controls:6.27%
cases:2.78%
controls:1.10%
—
—
cases:2.60%
controls:1.24%
cases:8.88%
controls:6.45%
cases:17.72%
controls:13.62%
98
942
911
9139
85
632
924
9449
28
111
981
9970
—
26
125
974
9934
87
634
893
9189
154
1183
715
7502
Mixed conductive and sensorineural hearing loss, bilateral
H90.6 [45601013]
H90.6 [45601013]
1.7e+00
—
—
—
—
—
—
cases:0.79%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
8
15
1001
10066
—
—
—
—
—
—
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
3.9e-02
3.2e-01
9.4e-01
—
7.4e-01
3.3e-01
3.1e-01
cases:9.71%
controls:9.37%
cases:8.42%
controls:6.27%
cases:2.78%
controls:1.10%
—
—
cases:2.60%
controls:1.26%
cases:8.78%
controls:6.45%
cases:17.72%
controls:13.63%
98
945
911
9136
85
632
924
9449
28
111
981
9970
—
26
127
974
9932
86
634
894
9189
154
1184
715
7501
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 [3027450]
17791-5 [3027450]
—
1.7e+00
—
—
—
1.2e+00
7.6e-01
—
—
cases:0.89%
controls:0.17%
—
—
—
—
—
—
cases:0.61%
controls:0.19%
cases:1.15%
controls:0.54%
—
9
17
1000
10064
—
—
—
6
19
974
9804
10
47
859
8638
Pure hypercholesterolaemia
E78.01 [2000501514]
E78.01 [2000501514]
-1.8e-01
5.3e-01
—
—
1.7e+00
4.2e-01
-7.7e-02
cases:2.18%
controls:2.61%
cases:2.28%
controls:1.36%
—
—
—
—
cases:1.20%
controls:0.23%
cases:2.35%
controls:1.55%
cases:4.72%
controls:5.08%
22
263
987
9818
23
137
986
9944
—
—
12
23
988
10036
23
152
957
9671
41
441
828
8244
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
103
57
20.00
130.37
1.8
2.0
—
—
—
0
0
459
2301
2.82
55.80
6.2
4.2
93.51
91.40
%
1.16
447
2252
257
1002
3.10
48.73
9.5
9.5
0.95
0.92
mmol/l
0.04
204
844
501
2777
2.59
47.79
2.5
2.2
144.74
238.73
u/l
1.91
488
2646
256
1013
3.04
47.14
9.6
9.5
16.68
12.43
kpa
13.45
250
986
256
1013
3.04
47.14
9.7
9.5
5.10
5.13
kpa
0.21
250
983
405
2229
2.36
36.77
2.6
2.4
—
—
—
0
0
602
4065
2.18
31.56
8.9
7.1
1.20
1.21
mmol/l
3.31
573
3774
645
4531
2.16
29.80
8.9
7.7
1.20
1.21
mmol/l
2.35
573
3943
590
4021
2.12
29.32
13.1
12.8
1.19
1.20
inr
0.39
483
3322
34
37
9.47
28.39
3.3
3.3
28.50
32.77
umol/l
0.70
24
26
719
5344
2.18
27.69
7.7
5.4
6.42
6.63
mmol/l
2.74
696
5069
605
4256
2.04
26.44
3.0
2.8
—
—
estimate
—
0
0
171
822
2.30
19.76
12.2
9.2
1.32
1.30
mmol/l
0.08
164
812
379
2530
1.79
16.92
4.1
3.3
0.37
0.43
e6/l
0.29
275
1836
261
1559
1.91
16.61
4.0
3.6
0.82
0.82
mmol/l
0.11
247
1485
67
222
3.16
16.13
2.6
1.4
554.69
645.93
e6/l
0.06
52
169
66
220
3.14
15.73
2.5
1.3
63.41
27.46
e6/l
0.38
46
161
418
2940
1.72
15.10
4.1
3.4
29.73
74.65
e6/l
1.21
313
2232
463
3397
1.67
13.95
4.9
4.0
100.82
90.09
e6/l
0.12
324
2356
252
1594
1.77
12.92
3.4
3.0
1.54
1.01
e6/l
1.16
133
844
230
1475
1.72
11.04
3.6
3.1
2.52
2.45
e6/l
0.04
109
731
968
8990
2.66
10.38
25.2
17.8
139.58
139.67
mmol/l
0.49
954
8832
154
896
1.85
10.23
2.2
2.5
32.43
44.03
u/l
1.18
131
752
956
8838
2.41
10.19
21.4
15.4
24.35
23.50
mg/l
0.34
840
7213
196
1245
1.71
9.62
5.3
6.2
1.04
1.04
mmol/l
0.04
181
1157
966
9005
2.51
9.50
25.1
18.0
3.95
3.97
mmol/l
1.28
951
8833
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
60
252
2.47
9.30
5.2
2.9
0.37
0.38
iu/ml
0.08
35
131
498
3961
1.51
9.23
5.3
5.3
35.81
36.06
g/l
0.44
474
3740
139
808
1.83
9.23
7.0
8.4
7.74
9.02
mmol/l
1.39
134
778
285
2011
1.58
9.17
3.2
2.7
5.28
6.05
e6/l
0.51
255
1835
431
3354
1.50
8.73
3.7
3.6
26.93
51.94
ng/l
0.73
312
2322
57
243
2.43
8.57
3.7
3.1
2.38
2.18
index
0.10
37
136
294
2130
1.54
8.28
2.6
1.8
1.33
1.16
mg/l
0.34
239
1643
579
4828
1.46
7.99
7.5
7.0
10.94
11.77
umol/l
0.92
549
4620
38
137
2.84
7.98
1.4
1.2
3.84
4.64
u/ml
0.14
19
56
37
135
2.81
7.61
1.0
1.1
—
—
—
0
0
239
1688
1.54
7.46
3.6
3.8
342.97
455.22
ng/l
0.26
177
1259
30
101
3.03
7.12
1.0
1.1
—
—
—
0
0
22
61
3.66
7.05
1.2
1.1
0.52
0.52
ratio
0.03
15
36
30
102
3.00
7.01
2.4
1.3
—
—
—
0
0
99
564
1.84
7.00
6.9
4.3
23.97
24.28
mmol/l
0.46
99
558
169
1121
1.61
6.88
3.7
3.0
8.63
7.31
umol/l
0.37
142
990
110
657
1.76
6.65
2.2
2.5
32.49
19.39
au/ml
0.57
11
64
28
97
2.94
6.35
1.0
1.1
—
—
—
0
0
614
5295
1.40
6.32
11.7
10.0
3.93
4.05
e9/l
0.70
518
4633
26
87
3.04
6.26
1.1
1.1
—
—
—
0
0
93
539
1.80
6.22
1.6
1.7
—
—
—
0
0
915
8546
1.72
6.20
20.1
14.5
84.59
83.55
ml/min/173m2
0.79
863
7896
17
32
5.38
6.17
1.1
1.8
79.88
90.47
%
—
8
17
17
32
5.38
6.17
1.1
1.2
76.63
89.06
%
—
8
17
982
9392
2.40
6.08
26.2
19.7
75.30
75.60
umol/l
0.10
971
9302
145
959
1.60
5.95
2.3
2.1
377.23
373.14
nmol/l
0.10
138
906
472
3922
1.38
5.92
2.0
2.1
95.58
96.45
pmol/l
0.15
242
2119
24
80
3.05
5.83
3.5
3.6
12.89
12.12
index
0.18
18
57
34
138
2.51
5.75
1.4
1.2
4.09
2.83
u/ml
0.31
11
46
766
6916
1.44
5.74
9.0
8.5
78.37
78.71
u/l
0.08
736
6572
705
6301
1.39
5.38
3.8
3.4
45.92
47.34
u/l
0.17
673
5977
21
68
3.13
5.36
1.0
1.1
—
—
—
0
0
182
1296
1.49
5.33
2.6
2.6
24.57
23.07
%
0.56
169
1225
568
4921
1.35
5.19
4.0
3.8
0.01
0.34
estimate
0.52
108
935
193
1406
1.46
5.03
2.5
2.6
2.25
2.34
g/l
1.25
177
1316
742
6719
1.39
5.01
4.6
4.4
10.34
11.31
mm/h
1.27
708
6308
132
890
1.56
4.98
6.4
4.2
1.38
1.93
mmol/l
0.77
124
763
563
4894
1.34
4.91
4.0
3.7
14.56
4.74
estimate
0.29
113
1009
261
2016
1.40
4.91
1.5
1.5
2.39
2.42
g/l
0.07
165
1259
557
4842
1.33
4.82
4.0
3.7
0.01
0.00
estimate
0.42
113
990
18
57
3.20
4.78
3.8
3.8
0.72
0.91
index
0.76
18
57
12
21
5.77
4.76
1.1
1.0
6.31
5.97
mg/g
0.11
12
21
16
48
3.37
4.62
2.6
1.5
—
—
—
0
0
884
8296
1.51
4.60
6.0
5.3
1.77
1.89
mu/l
2.55
832
7735
229
1748
1.40
4.59
2.9
2.8
2.43
2.44
mmol/l
0.69
198
1585
378
3125
1.33
4.55
3.8
3.6
2.36
2.35
mmol/l
0.06
345
2864
76
460
1.70
4.43
1.4
1.5
—
—
—
0
0
971
9345
1.90
4.31
14.0
12.1
27.09
26.38
u/l
0.25
943
9120
34
160
2.16
4.19
1.9
1.3
—
—
—
0
0
34
160
2.16
4.19
1.9
1.3
—
—
—
0
0
199
1509
1.40
4.11
2.6
2.6
13.57
13.43
umol/l
0.09
185
1416
105
704
1.55
4.07
1.9
2.4
5.56
7.40
ug/l
0.71
91
640
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
54
2.99
3.86
1.0
1.2
—
—
—
0
0
126
895
1.47
3.72
3.9
3.2
—
—
—
0
0
112
785
1.48
3.54
4.2
2.9
10.32
10.67
g/l
0.36
100
733
16
57
2.84
3.53
1.5
1.4
170.28
175.39
pmol/l
0.08
16
57
504
4436
1.27
3.51
3.5
3.1
124.66
120.91
ug/l
0.12
474
4178
193
1497
1.36
3.45
2.1
2.0
—
—
—
0
0
99
682
1.50
3.41
3.6
4.1
1.22
1.23
mmol/l
0.95
87
588
11
27
4.11
3.40
1.0
1.2
—
—
—
0
0
102
709
1.49
3.37
3.2
4.1
72.87
83.89
ng/l
0.85
90
631
95
651
1.51
3.36
1.6
1.6
—
—
—
0
0
306
2546
1.29
3.32
1.6
1.7
21.09
20.14
nmol/l
0.51
266
2178
10
23
4.38
3.31
1.6
1.7
17.94
17.76
umol/l
—
10
23
15
54
2.80
3.26
1.1
1.1
—
—
—
0
0
377
3226
1.27
3.25
4.0
3.4
34.02
32.29
u/l
0.22
364
3063
15
55
2.75
3.16
1.0
1.1
1.05
1.08
u/l
—
6
29
284
2356
1.29
3.12
2.5
2.3
2.59
2.84
mg/l
1.42
239
2045
277
2297
1.28
3.05
1.3
1.3
0.95
1.47
u/ml
0.78
74
636
122
896
1.41
3.03
2.6
2.5
0.22
0.21
g/l
0.07
113
844
7
12
5.86
3.02
1.1
1.4
—
—
—
0
0
77
519
1.52
2.97
1.8
1.4
29.73
26.77
iu/l
0.29
67
444
93
653
1.47
2.94
5.9
4.1
5.17
5.14
kpa
0.16
88
634
43
252
1.74
2.89
2.5
1.6
—
—
—
0
0
10
27
3.73
2.88
1.0
1.3
—
—
—
0
0
6
9
6.70
2.87
1.3
1.0
—
—
—
0
0
989
9662
1.92
2.83
32.5
23.4
252.45
252.40
e9/l
0.01
974
9493
989
9663
1.92
2.81
32.3
23.4
90.89
90.88
fl
0.04
982
9582
163
1271
1.34
2.80
2.0
2.5
162.64
108.71
ug/g
0.51
132
1030
989
9666
1.90
2.76
32.4
23.4
4.47
4.52
e12/l
2.33
973
9473
989
9666
1.90
2.76
33.8
24.0
40.22
40.53
%
1.31
982
9579
7
14
5.03
2.73
1.0
1.1
—
—
—
0
0
989
9668
1.90
2.73
32.6
23.6
134.33
135.96
g/l
3.00
983
9586
14
54
2.61
2.71
1.1
1.4
23.24
26.31
umol/l
0.13
14
47
6
10
6.03
2.70
1.0
1.7
—
—
—
0
0
12
43
2.81
2.65
1.1
1.2
—
—
—
0
0
80
559
1.47
2.62
6.0
4.1
2.01
1.69
mmol/l
0.35
56
416
7
15
4.69
2.60
1.0
1.1
—
—
—
0
0
58
380
1.56
2.57
1.2
1.2
0.26
1.37
u/ml
—
7
23
12
44
2.75
2.55
1.4
1.1
—
—
—
0
0
6
11
5.48
2.54
4.2
1.1
—
—
—
0
0
639
5896
1.23
2.52
3.2
3.1
—
—
—
0
0
12
45
2.69
2.45
1.3
4.0
156.20
124.56
umol/l
—
5
27
465
4168
1.21
2.42
2.5
2.5
76.56
76.38
nmol/l
0.04
423
3796
9
27
3.35
2.39
1.0
1.1
—
—
—
0
0
9
27
3.35
2.39
1.0
1.1
—
—
—
0
0
8
22
3.66
2.36
1.1
1.1
—
—
—
0
0
23
119
1.95
2.32
1.7
1.8
21.04
34.58
ng/l
0.73
23
119
9
28
3.23
2.31
1.0
1.1
—
—
—
0
0
142
1118
1.31
2.30
2.1
1.9
—
—
—
0
0
796
7548
1.25
2.29
27.5
18.9
13.57
13.56
%
0.08
791
7462
36
216
1.69
2.28
3.1
2.3
131.25
130.89
g/l
0.02
24
170
11
40
2.77
2.27
1.1
1.2
—
—
—
0
0
135
1060
1.32
2.23
2.1
1.9
—
—
—
0
0
98
733
1.37
2.23
2.8
2.6
78.10
68.32
ml/min/173m2
1.26
49
306
46
296
1.58
2.23
2.1
1.3
12.01
9.24
u/l
0.42
36
235
33
195
1.72
2.21
2.0
1.5
—
—
—
0
0
48
314
1.55
2.17
1.3
1.3
—
—
—
0
0
16
74
2.18
2.15
1.6
1.7
—
—
—
0
0
48
315
1.55
2.15
2.0
2.9
0.85
0.95
g/l
0.09
42
282
125
979
1.32
2.11
7.0
6.4
—
—
—
0
0
54
366
1.50
2.09
2.0
1.8
2.99
2.12
ug/l
0.21
46
335
16
75
2.15
2.09
2.2
1.3
125111.40
27784.35
e6/l
—
10
37
14
62
2.28
2.08
1.6
1.4
—
—
—
0
0
748
7081
1.21
2.00
4.9
4.4
14.72
14.72
pmol/l
0.02
703
6547
21
112
1.89
1.97
1.1
1.1
—
—
—
0
0
7
21
3.35
1.96
1.1
1.3
—
—
—
0
0
6
16
3.77
1.93
5.0
6.5
5.33
10.63
%
—
6
16
6
16
3.77
1.93
1.3
1.1
—
—
—
0
0
11
45
2.46
1.93
1.0
3.5
765.91
711.96
u/ml
0.10
11
45
78
578
1.38
1.91
4.2
3.8
4.44
4.64
pmol/l
0.96
73
521
37
236
1.59
1.89
1.2
1.2
29.34
37.85
u/ml
—
7
25
91
693
1.34
1.88
1.4
1.2
91.15
143.52
u/ml
0.89
33
284
46
312
1.50
1.81
2.4
1.8
44.54
39.37
nmol/l
0.49
46
298
45
304
1.50
1.80
1.7
1.8
—
—
—
0
0
124
993
1.28
1.80
5.0
4.7
238.86
251.67
u/l
0.50
115
949
34
218
1.58
1.72
2.1
1.8
—
—
—
0
0
5
13
3.86
1.71
1.0
1.1
—
—
—
0
0
41
275
1.51
1.71
1.7
2.8
0.00
0.00
g/l
-0.00
36
240
40
267
1.52
1.71
1.4
1.2
—
—
—
0
0
48
333
1.46
1.71
1.7
1.9
—
—
—
0
0
11
48
2.31
1.71
9.5
9.0
8.28
336.76
ug/l
—
6
34
78
594
1.34
1.64
2.2
3.0
168.55
170.84
ng/l
0.02
69
542
329
2940
1.18
1.63
3.0
2.6
64.49
60.96
u/l
0.22
299
2734
12
56
2.16
1.61
1.8
7.4
—
82.54
—
0
13
24
144
1.68
1.58
1.1
1.1
—
—
—
0
0
16
85
1.90
1.55
2.2
1.3
1523.60
1964.88
e6/l
—
10
52
12
57
2.12
1.55
1.3
1.9
30.33
28.34
umol/l
0.22
12
50
89
700
1.30
1.51
1.3
1.3
240.24
224.91
u/ml
0.05
81
648
8
169
0.47
1.47
1.3
1.7
—
—
—
0
0
10
45
2.23
1.46
3.3
2.0
—
—
—
0
0
10
45
2.23
1.46
1.2
1.4
153.10
187.08
mmol/24h
—
10
45
10
45
2.23
1.46
3.3
2.0
—
—
—
0
0
297
2653
1.17
1.46
3.9
3.9
0.00
0.01
estimate
1.34
106
935
13
66
1.98
1.43
1.2
1.7
10.91
12.85
umol/l
0.51
13
61
47
338
1.41
1.42
1.5
1.5
—
—
—
0
0
26
165
1.59
1.41
1.5
1.5
0.23
0.35
nmol/l
0.91
18
136
42
297
1.43
1.39
1.6
1.5
325.80
288.37
ug/g
0.70
30
181
210
1830
1.19
1.39
1.3
1.3
15.85
32.45
iu/ml
4.23
49
546
52
383
1.38
1.38
1.5
2.1
1.26
1.48
g/l
1.04
44
341
55
409
1.36
1.38
1.8
1.8
8.31
6.90
iu/ml
0.17
13
99
861
8350
1.21
1.35
6.3
6.2
38.26
39.03
mmol/mol
2.10
819
7880
16
90
1.79
1.33
7.0
5.6
50.70
45.74
u/ml
—
6
34
7
149
0.47
1.32
3.7
3.3
0.74
0.84
nmol/l
—
7
124
9
43
2.10
1.30
1.0
1.0
—
—
—
0
0
43
310
1.40
1.30
2.3
2.9
—
—
—
0
0
190
1652
1.18
1.30
3.4
3.2
0.69
0.76
ug/l
0.62
133
1039
421
3887
1.14
1.29
2.1
1.9
1.33
1.36
mmol/l
0.24
364
3311
99
808
1.25
1.27
3.3
2.3
14.35
13.27
nmol/l
0.46
92
734
17
99
1.73
1.27
1.2
1.2
—
—
—
0
0
50
373
1.36
1.25
7.3
4.7
25.27
24.76
mmol/l
0.63
43
355
40
288
1.40
1.23
1.4
1.2
2.84
8.13
u/ml
—
9
48
67
524
1.30
1.22
1.0
1.1
—
—
—
0
0
8
38
2.11
1.18
9.8
4.3
—
—
—
0
0
280
2530
1.15
1.17
3.1
3.1
872.17
1053.13
ng/l
0.60
246
2146
8
39
2.06
1.15
2.1
2.2
—
—
—
0
0
914
8941
1.22
1.14
6.0
5.7
2.70
2.74
mmol/l
0.68
861
8391
139
1190
1.19
1.14
1.8
1.8
1.50
1.49
%
0.06
125
1055
12
65
1.86
1.13
6.0
2.1
30.71
34.57
mg/l
—
7
46
267
2410
1.15
1.13
2.9
2.8
327.04
339.25
umol/l
1.17
236
2146
23
151
1.54
1.12
1.7
1.3
—
—
—
0
0
20
128
1.57
1.09
1.0
1.9
—
1744.00
—
0
5
56
439
1.29
1.03
4.5
4.0
50.81
47.91
%
0.46
56
431
46
353
1.32
0.99
2.5
2.3
2196.19
6001.30
u/l
0.90
18
144
5
23
2.18
0.98
1.4
1.2
—
—
—
0
0
14
84
1.68
0.98
1.2
1.2
0.13
4.85
u/ml
—
5
42
14
84
1.68
0.98
1.4
1.1
—
43.20
—
0
5
874
8539
1.17
0.97
5.0
5.0
5.85
5.91
mmol/l
0.70
815
7927
18
116
1.56
0.97
3.7
2.3
32.06
32.74
pg
0.28
18
116
17
108
1.58
0.97
1.4
1.2
—
—
—
0
0
861
8407
1.16
0.94
4.5
4.3
1.28
1.30
mmol/l
0.43
805
7814
20
135
1.49
0.89
1.2
1.0
0.46
0.44
u/ml
—
10
48
6
30
2.01
0.87
1.2
1.7
—
—
—
0
0
391
3667
1.11
0.86
4.0
3.6
0.07
0.02
estimate
0.50
90
819
8
141
0.56
0.83
1.6
1.6
37.74
51.15
ug/l
—
8
141
21
146
1.45
0.83
1.1
1.1
3.30
4.71
u/ml
0.24
12
61
8
46
1.74
0.82
1.0
1.1
121.19
227.76
iu/ml
—
8
46
91
776
1.19
0.82
2.4
2.4
0.51
0.42
e6/l
0.22
86
743
13
200
0.65
0.80
1.9
1.7
—
—
—
0
0
8
48
1.67
0.79
1.1
1.1
—
—
—
0
0
14
90
1.56
0.78
1.1
1.1
—
—
—
0
0
17
115
1.49
0.77
1.3
1.2
—
—
—
0
0
6
34
1.77
0.76
2.2
1.9
36.10
41.47
g/l
—
6
34
25
183
1.38
0.76
1.2
1.6
176.36
149.93
au/ml
1.17
11
55
184
1670
1.12
0.73
1.3
1.3
12.36
11.43
u/ml
0.06
83
655
46
371
1.25
0.73
1.5
1.6
27.15
11.31
u/ml
0.51
11
85
22
159
1.39
0.72
1.2
1.0
3.37
4.91
u/ml
0.22
13
78
13
84
1.55
0.72
1.1
1.2
—
—
—
0
0
13
84
1.55
0.72
1.1
1.2
—
—
—
0
0
26
195
1.34
0.70
2.0
1.5
—
—
—
0
0
17
118
1.45
0.69
1.4
1.3
0.13
0.18
nmol/l
—
10
89
32
248
1.30
0.69
2.5
1.7
—
—
—
0
0
55
456
1.22
0.69
1.5
1.6
0.35
0.35
mg/l
0.04
24
212
16
110
1.46
0.68
1.1
1.9
—
—
—
0
0
898
8834
1.14
0.68
5.3
5.1
4.62
4.67
mmol/l
0.68
845
8322
17
119
1.44
0.67
3.5
1.7
—
—
—
0
0
338
3182
1.09
0.67
3.4
3.5
8.10
7.81
mmol/l
0.47
286
2726
24
181
1.33
0.63
1.2
1.1
0.06
1.51
u/ml
2.74
11
97
13
87
1.50
0.63
1.9
1.4
6.75
6.23
mmol/l
0.19
13
82
34
270
1.27
0.63
1.9
2.0
2.10
4.11
iu/l
2.47
11
112
13
88
1.48
0.60
2.3
2.6
1.20
1.19
mmol/l
0.27
13
88
27
210
1.29
0.59
1.1
1.1
2.91
2.61
u/ml
0.05
17
120
14
97
1.45
0.59
1.1
2.0
—
—
—
0
0
13
89
1.47
0.58
2.3
2.6
4.08
4.07
mmol/l
0.09
13
89
13
89
1.47
0.58
2.3
2.6
105.69
105.02
mmol/l
0.34
13
89
8
54
1.49
0.57
1.0
1.4
—
538.00
—
0
5
12
81
1.49
0.57
1.1
1.2
—
—
—
0
0
316
2988
1.08
0.56
4.1
4.2
7.28
8.07
mg/mmol
0.15
191
1875
6
37
1.63
0.55
1.8
1.1
28.77
32.87
nmol/l
—
6
27
12
82
1.47
0.54
1.1
1.2
—
—
—
0
0
51
433
1.19
0.53
3.9
3.2
1.02
1.02
ratio
0.43
43
406
9
64
1.41
0.51
1.3
1.2
—
—
—
0
0
13
92
1.42
0.50
3.0
3.7
—
—
—
0
0
196
1826
1.09
0.50
1.5
1.6
—
—
—
0
0
233
2189
1.08
0.49
4.2
4.4
21.74
21.24
%
0.23
109
1011
31
253
1.23
0.48
1.1
1.2
—
—
—
0
0
31
253
1.23
0.48
1.1
1.2
—
—
—
0
0
17
128
1.33
0.48
1.0
1.1
—
—
—
0
0
30
245
1.23
0.47
1.4
1.3
—
—
—
0
0
30
364
0.82
0.47
1.1
1.1
1.53
1.54
g/l
0.03
30
364
19
242
0.78
0.45
1.5
1.6
5296.00
13491.98
e6/l
—
8
175
10
69
1.45
0.44
3.0
2.8
1097.00
1018.77
mg
—
10
69
194
1819
1.08
0.43
1.7
1.7
432.15
31572511.76
pmol/l
1.91
164
1533
891
8804
1.10
0.43
5.2
5.0
1.46
1.46
mmol/l
0.07
838
8246
5
32
1.57
0.42
2.0
1.3
—
—
—
0
0
27
222
1.22
0.41
2.4
1.6
—
—
—
0
0
0
16
0.00
0.41
0.0
9.1
—
10.63
—
0
16
285
2721
1.07
0.39
5.6
5.3
1.86
2.34
ug/l
1.35
261
2476
5
35
1.43
0.39
3.6
1.7
—
—
—
0
0
9
66
1.37
0.38
10.1
2.7
—
—
—
0
0
5
36
1.39
0.38
1.0
2.9
22.34
239.49
ug/l
—
5
31
9
67
1.35
0.38
1.1
1.2
—
—
—
0
0
13
98
1.33
0.37
1.5
1.1
—
61.88
—
0
8
123
1140
1.09
0.37
1.9
2.1
—
—
—
0
0
148
1385
1.08
0.36
1.7
1.7
1036.59
1194.81
nmol/l
1.46
110
1047
31
263
1.18
0.36
1.9
4.0
2.16
2.53
ratio
0.15
17
154
22
180
1.23
0.36
3.5
3.3
7.51
8.68
pmol/l
0.29
22
180
6
42
1.43
0.35
1.5
1.5
—
—
—
0
0
99
915
1.09
0.33
4.1
4.7
11.12
23.91
ug/l
0.69
72
757
6
46
1.31
0.33
1.0
1.1
1.02
1.06
ratio
—
6
39
6
47
1.28
0.32
1.2
1.8
—
—
—
0
0
6
47
1.28
0.32
1.2
1.8
—
—
—
0
0
6
47
1.28
0.32
1.2
1.8
—
—
—
0
0
6
47
1.28
0.32
1.2
1.8
—
—
—
0
0
160
1510
1.07
0.32
1.5
1.5
—
—
—
0
0
13
101
1.29
0.31
1.4
1.2
—
—
—
0
0
43
380
1.14
0.31
4.0
3.5
25.52
25.24
mmol/l
0.25
43
370
36
411
0.87
0.31
1.5
1.6
1238.61
961.32
mu/l
0.61
31
350
20
165
1.22
0.31
2.9
1.9
—
—
—
0
0
7
53
1.32
0.31
1.1
1.4
—
—
—
0
0
7
54
1.30
0.30
2.4
1.6
—
—
—
0
0
33
287
1.15
0.30
1.3
1.3
—
—
—
0
0
74
803
0.92
0.28
1.6
1.7
3.25
3.52
mmol/l
1.21
51
584
8
62
1.29
0.28
1.4
1.5
84.25
78.48
umol/l
—
8
62
100
1068
0.93
0.27
1.9
2.0
3.47
3.51
ratio
0.10
76
846
30
262
1.15
0.27
2.8
1.7
—
—
—
0
0
11
86
1.28
0.26
2.5
1.8
—
—
—
0
0
34
382
0.89
0.25
1.3
1.2
0.84
0.90
g/l
1.03
34
382
11
87
1.27
0.24
1.2
1.7
—
—
—
0
0
11
87
1.27
0.24
1.2
1.7
—
—
—
0
0
11
87
1.27
0.24
1.2
1.7
—
—
—
0
0
12
97
1.24
0.23
1.0
1.3
—
—
—
0
0
24
274
0.87
0.22
1.9
1.5
—
—
—
0
0
23
200
1.15
0.22
3.3
2.3
91.91
102.81
ug/min
0.08
12
121
24
210
1.15
0.22
4.5
3.0
1.32
1.56
mmol/l
1.37
24
205
5
42
1.19
0.21
1.2
3.0
—
63809.00
—
0
7
5
42
1.19
0.21
3.8
1.8
107.80
60.95
ug/l
—
5
42
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
274
2661
1.04
0.21
3.5
3.1
0.04
0.04
estimate
0.01
89
803
0
12
0.00
0.21
0.0
1.1
—
10.75
—
0
12
10
80
1.25
0.20
1.0
1.1
91.80
111.26
pmol/l
—
10
80
6
48
1.25
0.20
1.2
1.3
529.50
502.19
u/l
—
6
43
22
193
1.14
0.19
1.8
1.5
—
—
—
0
0
70
656
1.07
0.19
1.7
2.0
—
—
—
0
0
28
310
0.90
0.17
1.4
1.5
0.07
0.09
iu/ml
—
8
44
12
142
0.84
0.17
1.0
1.1
2.91
1.98
eliau/ml
—
7
60
36
392
0.92
0.17
1.2
1.8
6.20
3.60
mg/l
0.43
28
291
23
205
1.12
0.17
1.3
1.3
256.33
261.13
u/ml
0.03
18
113
5
66
0.76
0.17
1.0
1.8
—
—
—
0
0
220
2147
1.03
0.14
4.1
3.8
1.02
1.02
kg/l
0.18
143
1443
15
170
0.88
0.13
6.7
4.2
32.87
30.47
u/ml
0.06
15
165
25
228
1.10
0.13
1.4
1.4
—
—
—
0
0
108
1043
1.04
0.12
1.9
2.0
—
—
—
0
0
25
230
1.09
0.11
1.4
1.5
0.99
0.95
ratio
0.18
12
145
25
230
1.09
0.11
1.4
1.5
1.38
1.10
ratio
0.42
12
145
25
230
1.09
0.11
1.4
1.5
1.01
1.16
ratio
0.54
13
145
26
242
1.08
0.09
1.3
1.5
71.59
60.31
ug/l
0.39
20
212
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
11
124
0.89
0.09
4.4
1.7
—
—
—
0
0
6
54
1.11
0.09
2.7
1.6
—
—
—
0
0
6
58
1.03
0.08
1.3
1.2
—
—
—
0
0
16
146
1.10
0.08
1.0
1.1
—
1.11
—
0
7
7
65
1.08
0.08
2.3
1.7
—
—
—
0
0
28
297
0.94
0.08
1.2
1.3
—
—
—
0
0
45
469
0.96
0.07
1.5
1.4
—
—
—
0
0
20
186
1.08
0.07
2.6
1.6
—
—
—
0
0
7
82
0.85
0.07
1.0
1.4
—
—
—
0
0
9
84
1.07
0.07
2.0
2.4
—
—
—
0
0
34
325
1.05
0.06
1.2
1.3
205.53
256.80
miu/ml
0.45
19
149
24
252
0.95
0.05
1.1
1.4
—
—
—
0
0
108
1095
0.98
0.03
4.2
4.7
32.27
32.11
%
0.05
74
740
69
703
0.98
0.03
1.8
1.5
—
—
—
0
0
11
102
1.08
0.03
3.6
3.8
60.36
54.39
%
0.55
11
93
12
128
0.94
0.02
1.2
1.4
—
—
—
0
0
12
128
0.94
0.02
1.3
1.4
—
—
—
0
0
27
261
1.04
0.02
1.3
2.4
10.85
11.54
mg/l
0.17
27
242
15
158
0.95
0.02
1.3
1.7
—
—
—
0
0
31
318
0.97
0.02
1.4
1.5
—
—
—
0
0
12
126
0.95
0.00
1.3
1.4
—
—
—
0
0
36
366
0.98
0.00
1.7
1.8
—
—
—
0
0
13
134
0.97
0.00
1.2
1.5
—
—
—
0
0
12
122
0.98
0.00
1.3
1.4
—
—
—
0
0
55
554
0.99
0.00
1.6
1.9
—
—
—
0
0
12
121
0.99
0.00
1.3
1.4
—
—
—
0
0
12
121
0.99
0.00
1.2
1.4
—
—
—
0
0
15
151
0.99
0.00
1.9
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
64
0.94
0.00
1.0
1.0
750.83
667.62
ng/l
—
6
45
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
26.33
—
0
6
0
6
0.00
0.00
0.0
1.0
—
2.67
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.8
—
3.84
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
59
1.02
-0.00
2.7
1.6
—
—
—
0
0
5
58
0.86
-0.00
2.6
1.9
68.40
109.34
ng/l
—
5
58
0
5
0.00
-0.00
0.0
6.4
—
—
—
0
0
8
84
0.95
-0.00
1.1
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
7.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
4.2
—
5.69
—
0
9
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
5.91
—
0
8
0
9
0.00
-0.00
0.0
1.2
—
0.56
—
0
9
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM | 1.412 [1.2, 1.67] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.218 |
During the follow-up period (1.1.1998 — 31.12.2019), 247 out of 2415 females with Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM | 1.509 [1.28, 1.78] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.02 |
During the follow-up period (1.1.1998 — 31.12.2019), 309 out of 2209 males with Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM died.
Mortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.111% | 0.301% |
| 5 | 0.689% | 1.751% |
| 10 | 1.803% | 4.426% |
| 15 | 3.836% | 8.529% |
| 20 | 6.932% | 14.452% |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_CIRCULATO_SYSTEM – Other congenital malformations of circulatory system
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data